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DIF   direct immunofluorescence
Dsc  desmocollin
Dsg  desmoglein 
ECS  epithelial cell surface
ELISA  enzyme-linked immunosorbent assay
Fab  fragment antigen-binding
H&E  hematoxylin and eosin
ICS  intercellular substance
IgG  immunoglobulin G
IIF  indirect immunofluorescence
N-  Nikolsky negative
N+  Nikolsky positive
PE  pemphigus erythematosus
PF  pemphigus foliaceus
PG  plakoglobin
PH  pemphigus herpetiformis
PNP  paraneoplastic pemphigus
PV  pemphigus vulgaris
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The term pemphigus is derived from the Greek word pemphix, which means blister. Pemphigus 
is a group of chronic mucocutaneous blistering diseases caused by autoantibodies directed 
against the desmosomal cadherins desmoglein (Dsg)1 and/or Dsg3. Pemphigus is characterized 
macroscopically by blisters and erosions of the skin and/or mucous membranes and microscopi-
cally by acantholysis.1,2 
Epidemiology
Pemphigus has a worldwide incidence of 0.76–5 cases per 1,000,000 per year.1 The incidence 
of the different subtypes of pemphigus varies from country to country. Pemphigus vulgaris (PV) 
and the sporadic form of pemphigus foliaceus (PF) are most common in Europe and the USA. 
The incidence of PF in these countries is about a fifth to a tenth of that of PV.3 Endemic PF is 
frequently diagnosed in rural areas of Brazil and other underdeveloped areas of the world.4 
Pemphigus affects all races but is diagnosed more often in people of Ashkenazi Jewish, Greek 
and Indian descent.5 
The expression of various HLA alleles may play a role in the epidemiology of pemphigus.2 PV is 
associated with HLA–DRB1*0402 in Ashkenazi Jews and DRB1*1401/1404 and DQB1*0503 in 
non–Jewish patients of European or Asian descent.3–7 Sporadic forms of PF are associated with 
HLA DRB1*0102 and 04043,4, while endemic PF is associated with HLA DRB1*0102, 0404, 
1402, and 1406.8 
The mean age of onset of the disease is approximately 50–60 years.1 However, pemphigus is 
also described in adolescents, children and the elderly.2 The endemic form of PF mostly affects 
teenagers and individuals in their 20s.4 The male–to–female ratio is almost equal, however in 
puberty, girls are more often affected than boys.2 
Pemphigus subtypes
Pemphigus can be divided into two major forms, based on the level of the blistering in the epi-
dermis: PF and PV. Other members of the pemphigus group include paraneoplastic pemphigus 
(PNP), drug induced pemphigus and IgA–pemhigus (Table 1). 
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Pemphigus subtypes
Pemphigus foliaceus (PF)
 – sporadic PF (Cazenave type)
 – endemic PF (fogo selvagem, Brazilian pemphigus) 
 – pemphigus erythematosus (Senear–Usher syndrome)
 – pemphigus herpetiformis
Pemphigus vulgaris (PV)
 – mucosal-dominant PV
 – mucocutaneous PV
 – pemphigus vegetans
  – Neumann type
  – Hallopeau type
IgA–pemphigus
 – subcorneal pustular dermatosis (SPD)
 – intraepidermal neutrophilic (IEN) IgA dermatosis
Paraneoplastic pemphigus (PNP)
Drug–induced pemphigus
Table 1 – Pemphigus subtypes
Pemphigus foliaceus
The superficial forms of pemphigus are grouped under pemphigus foliaceus, including sporadic 
PF (Cazenave type), endemic PF, pemphigus erythematosus, and pemphigus herpetiformis.
Sporadic pemphigus foliaceus
Pemphigus foliaceus was described for the first time in 1844 by Cazenave. Patients with PF 
develop multiple, pruritic, scaling, nummular lesions. The lesions usually have a seborrhoic 
distribution and prefer the face, scalp and upper trunk (Figure 1a). The lesions are present on 
healthy looking skin and have been described as cornflakes or puffed pastry (Figure 1b). The 
level of blistering in PF is so superficial (subcorneal) that intact blisters are rarely present and 
only the resultant scaling and crust are seen. The disease often starts with a few transient lesions 
which may be mistaken for impetigo, seborrhoic dermatitis or actinic keratoses. The disease 
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may stay localized for years or it may progress rapidly. In some cases the disease generalizes and 
evolves into an erythroderma. The Nikolsky sign is positive. It is extremely rare for patients with 
PF to develop mucosal involvement.1,2,4 Generally patients with PF are not severely ill, but they 
can complain of itching, burning and pain of the skin lesions. 
Pemphigus erythematosus
Pemphigus erythematosus (PE) is also called the Senear–Usher syndrome, according to the 
names of the authors who first described this variant.9 The disease is localized on the face and is 
characterized by erythematous, scaly, hyperkeratotic or crusted lesions often in a butterfly distri-
bution that resembles lupus erythematosus2,4 (Figure 1c). In addition to the intercellular deposits 
of antibodies that are present in all forms of pemphigus there are often granular deposits of 
immunoglobulin and/or complement present at the dermal–epidermal junction.2,4 
Endemic pemphigus foliaceus (Fogo selvagem, Brazilian PF)
This form of pemphigus occurs endemically in Brazil and in certain rural areas of the world and is 
clinically, histologically and immunopathologically indistinguishable from PF.2,4 
Pemphigus herpetiformis
Pemphigus herpetiformis (PH) is one of the less common forms of pemphigus, which was 
described for the first time by Jablonska in 1975.10 Most patients have a variant of PF and the re-
mainder may have a variant of PV.1 Skin lesions are similar to dermatitis herpetiformis, including 
erythematous, vesicular, bullous or papular lesions, which are often grouped and are severely 
pruritic. PH often presents with annular lesions, probably resulting from centrifugal spread 
of inflammatory processes. PH resembles other autoimmune bullous diseases like linear IgA 
dermatosis and IgA pemphigus. The affected sites are the trunk and proximal extremities, while 
mucous membranes are spared in most cases.11 PH is histologically characterized by eosinophilic 
spongiosis, subcorneal pustules and minimal acantholysis.10 Direct immunofluorescence (DIF) 
shows autoantibodies directed against Dsg1 in most cases and against Dsg3 in the rest.12
 
Pemphigus vulgaris
The deep forms of pemphigus are pemphigus vulgaris and its variant pemphigus vegetans.
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Pemphigus vulgaris
Almost all patients with PV have painful erosions of the oral mucosa. Patients with mucocu-
taneous PV (more than half of the patients) also develop blisters and cutaneous erosions. In 
mucosal-dominant PV, there are only oral lesions present (Figure 1e).
The mucous membranes are often affected first. The blisters rupture easily and lead to erosions 
in the oral cavity. Although the erosions may be seen anywhere in the oral cavity, the most 
common sites are the buccal mucosa, palate and tongue.1,2,4 The erosions extend peripherally 
and may spread to involve the pharynx and larynx with difficulty in eating and drinking and 
hoarseness of the voice.1,2 Also the nasal cavity can be involved.4 Involvement of other mucosal 
surfaces can be present including the conjunctiva, oesophagus, vulva, cervix, urethra and rectal 
mucosa.1,2,4
After weeks to months, the disease progresses with lesions appearing on the skin (Figure 1d). 
Sometimes, skin lesions are the first sign of the disease.4 The first lesion of the skin is a blister 
that is filled with a clear fluid, on a normal or erythematous skin, which breaks easily resulting in 
painful erosions. The fluid within the blisters may become hemorrhagic, turbid or even seropuru-
lent.1 When there is no treatment, the erosions enlarge to form large denuded areas, which may 
become crusted and may lead to complications as infections or metabolic disturbances or both. 
Before systemic corticosteroids became available, about 75% of patients who developed PV died 
within a year.4 Blisters may be present anywhere, but the scalp, upper chest and back are most 
often affected. The face and neck may also be involved. Although relatively rare, periungual and 
nail involvement must not be missed.2,4 
A characteristic feature of all forms of active and severe pemphigus is the Nikolsky sign, 
produced when lateral pressure is applied adjacent to a lesion leading to separation of the 
epidermis. The lack of cohesion of the skin may also be demonstrated with the bulla–spread 
phenomenon (Asboe–Hansen sign). 
With treatment, the lesions of PV generally heal with crusting followed by re–epithelialisation. 
There is no scarring, although transient residual hyperpigmentation may be present. This 
hyperpigmentation may be present for many months. Mild forms of the disease can even regress 
spontaneously. Most patients with PV eventually enter a phase of complete remission in which 
they can be maintained lesion–free with minimum doses of corticosteroids or without any 
therapy. As medications are tapered, flares in disease activity with development of new lesions 
and itching are not uncommon. 
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Figure 1 – Clinical features of pemphigus foliaceus (PF) and pemphigus vulgaris (PV). (a) Erosions on the skin in a patient 
with PF. (b) Puffed pastry like scaling in PF. (c) Erythema and crusts on the face in a patient with pemphigus erythematosus. 
(d) Extensive erosions on the back of a patient with mucocutaneous PV. (e) Erosions of the oral mucosa in a patient with 
mucosal-dominant PV. (f) Pemphigus vegetans with pustules in the inguinal region.
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Pemphigus vegetans
Pemphigus vegetans is a rare variant of PV in which healing is associated with vegetating 
plaques on the skin (Figure 1f). Lesions usually appear in intertriginous areas (axillae, groin and 
inframmamary area) and on the scalp or face. Pustules characterize early lesions, but these soon 
progress to vegetative plaques. The tongue may show cerebriform–like changes.1 Two subtypes 
are recognized: the papillomatous Neumann type and the pustular Hallopeau type. Because 
of their location the lesions are generally secondarily infected. The vegetative response may 
occasionally also be seen in lesions of PV that tend to be resistant to therapy and remain for long 
periods of time in one location.1
Desmosomes
Desmosomes are intercellular junctions that are present in epithelia and some nonepithelial 
tissues such as cardiac muscle and the meninges. They are present in large numbers in tissues 
that withstand mechanical stress such as the epidermis. Their most important function is to 
provide strong intercellular adhesion and to link the intermediate filament cytoskeleton into a 
tissue–wide scaffolding giving strength to tissues.13
History
In 1864, Giulio Bizzozero, described desmosomes for the first time.14,15 He examined the stratum 
spinosum by light microscopy and noted small nodules at the cell–cell contact points, which 
were named “nodes of Bizzozero”.15,16 He interpreted these nodes as contact points between 
two adjacent separately contributing cells.15
Later, in 1920, the term desmosome was introduced by Josef Schaffer. This term comes from the 
Greek word desmos, meaning “bond” and “some” meaning “body”.15–17 In that time Schaffer 
and others, thought that desmosomes were intercellular bridges filled with cytoplasm.14
Ninety years later, electron microscopy made it possible for Porter to confirm Bizzozero’s obser-
vation that desmosomes are contact points between adjacent cells.14,15 Improvement of electron 
microscopic techniques showed the lack of continuity between adjacent cells and electron–dense 
plates separated by a light space, with fibers extending from the membrane to the inside of the 
cell.15
In 1958, George Odland described these electron dense plates for the first time. Odland 
reinterpreted the nodes of ‘Bizzozero’ and described that they had seven layers with different 
densities.15 The layers occupied a space of 350 Å and had fibrils terminating at the attachment 
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plaques.15 At the end of the millennium an international group of cell biologists reported the 
molecular map of the desmosome.18
 
Figure 2 – Electron microscopy picture of a desmosome at the level of the spinous layer. DM = dense midline. PM = plasma 
membrane. ECD = extracellular core domain. ODP = outer dense plaque. IDP = inner dense plaque. KIFs = keratin interme-
diate filaments. Scale bar = 200nm. 
 
Ultrastructure 
Desmosomes are oval shaped junctions with a diameter of about 0.2–0.5 µm, but they may be 
as small as 0,1 µm or as large as several micrometers.14,16 The desmosomes are composed of two 
electron–dense plaques, one in each of the two adjacent cells, separated by an intercellular space 
of 24–30nm (Figure 2).14,16 The intercellular space is penetrable by water and ions and filled 
with electron–dense material, the desmoglea or extracellular core domain (ECD).13,16 In mature 
desmosomes a distinct line can be seen in the middle, which is named the dense midline (DM).16 
The plaques are 15–20 nm in size and are separated by a 10– to 20–nm gap.16 Thus, the total 
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thickness of the desmosomal plaque is 40–50 nm and the total thickness of a desmosome of 
the order of 130 nm.13 Within the plaques, an outer dense plaque (ODP) that is adjacent to the 
plasma membrane can be distinguished from a less dense inner plaque (IDP) facing the cyto-
plasm.14,16 The inner dense plaque is connected to the intermediate filaments.14
Composition of the desmosome 
Desmosomes are composed of members of at least three protein families: 1) cadherins, 2) 
armadillo proteins, and 3) plakins.14,17 Transmembrane members of the cadherin family, the 
desmogleins and desmocollins, form the intercellular adhesive interface. Proteins from the 
armadillo and plakin family form the plaques. The cytoplasmic tail of desmogleins and desmocol-
lins binds with plakoglobin (PG) which then binds to desmoplakin.14 Desmoplakin is connected 
to the intermediate filament cytoskeleton.14 The interactions are stabilized laterally by plakophilin 
(Figure 3).14
Figure 3 – Schematic drawing of a desmosome and an adherens junction. The autoantigens desmoglein 1 and desmoglein 3 
are depicted in blue. Drawing by M.F. Jonkman.
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Cadherins
The desmosomal members of the cadherin family are single–pass transmembrane glycoproteins, 
which provide adhesion in a Ca2+–dependent manner.14 In humans there are seven desmosomal 
cadherins, four desmogleins (Dsg1–4) and three desmocollins (Dsc 1–3).17,19 The Dsc genes give 
rise to two isoforms, Dsc a and b.14,17,19
The amino–terminal extracellular domain of desmosomal cadherins consists of four cadherin 
repeats (EC1–4) which are each about 110 amino acids followed by a membrane–proximal 
domain (EC5)14 or extracellular anchor (EA) domain.19 Within the cell, both desmocollin ‘a’ and 
‘b’ proteins have an intracellular anchor (IA) domain but only ‘a’ form proteins have an intracel-
lular cadherin–like sequence (ICS) domain,19 which provides a binding site for other desmosomal 
components such as PG.14,17,19 The b isoform is therefore unable to bind PG but binds with 
plakophilin 3 instead.14 The cytoplasmic tails of desmoglein also have IA and ICS domains.19 
Other domains in the cytoplasmic tails of desmoglein are the intracellular proline–rich linker (IPL) 
domain, a repeat unit domain (RUD) and a glycine rich desmoglein terminal domain (DTD).19
Simple epithelia express only Dsg2 and Dsc2. Stratified epithelia such as the epidermis, express 
Dsc1, Dsc3, Dsg1 and Dsg3. Low levels of Dsg2/Dsc2 are present in the basal layers and small 
amounts of Dsg4 are expressed in the granular and cornified layers.17 Different isoforms are 
expressed in the same individual cells and single desmosomes contain more than one desmocol-
lin and more than one desmoglein.19
Most desmosomes exhibit calcium–independent adhesion and are “hyperadhesive” desmosomes 
according to the hypothesis of Garrod. Hyperadhesion seems to be associated with an ordered 
arrangement of the extracellular domains of the desmosomal cadherins, which results in the 
intercellular midline visible by electron microscopy. Protein kinase C downregulates hyperadhe-
sion.20
Armadillo proteins
Armadillo family members are characterised by the presence of a central domain containing a 
variable number of 42 amino acid repeats (arm repeats). Armadillo proteins found in desmo-
somes are PG and the plakophilins, of which there are three (PKP1–3).19
Plakoglobin is the only desmosomal component which is also found in adherens junctions.14 
Plakoglobin contains 12 arm repeats.19 Plakoglobin binds to the intracellular ICS domain of 
desmogleins and desmocollins with its first three armadillo repeat domains.14 Plakoglobin also 
interacts with other desmosomal components like desmoplakin and plakophilins and with  
cytokeratin filaments.14 Plakoglobin may be involved in regulating lateral association between 
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other desmosomal components and desmosome size.19 Besides having a structural role in desmo-
somes and adherens junctions, PG plays a role in intracellular signal transduction14,19 and there 
is evidence that PG is important in regulating cross–talk between desmosomes and adherens 
junctions.19
The plakophilins contain 9 arm repeats with a flexible insert between repeats 5 and 6 that intro-
duces a major bend in the overall structure.19 There are two isoforms of plakophilins 1 and 2, a 
shorter a form and a longer b form, which are formed by alternative splicing.14,19 Plakophilins can 
directly interact with all other desmosomal components and the intermediate filaments through 
the aminoterminal head domain.14
Plakophilins 1–3 are expressed in the epidermis where they have differentiation–specific patterns 
of expression.19 All three plakophilins can be present in both desmosomes and the nucleus. 
PKP1b is only localized in the nucleus.14,19
Plakophilin 1 is responsible for bringing desmosomal components to the cell membrane and 
increasing size and number of desmosomes and is therefore an important protein which induces 
desmosome assembly.14 Besides its function in the regulation of desmosome assembly, plakophil-
ins may also regulate signalling mechanisms, both at cell borders as well as in the nucleus.14
Plakins
Proteins from the plakin family form the link between the cytoskeleton and cell–cell or cell–ma-
trix contacts. There are two splice variants of desmoplakin. Desmoplakin is a very important 
component of the desmosomal plaque and therefore is the most important protein of the plakin 
family. Other members such as plectin, envoplakin en periplakin are also found in desmosomes, 
but it is not clear how important they are for the structure and function of desmosomes.14
Desmoplakin is composed of three parts, a globular head or plakin domain, a coiled–coil rod 
domain and a tail domain.19 The globular head is an important region for protein–protein inter-
actions.19 Desmoplakin can interact with all other desmosomal proteins like PG, plakophilins and 
Dsc1a.14 The central coiled–coil rod domain is important for dimerization.14,19 The C–terminal tail 
domain consists of three plakin repeat domains (PRDs) named A, B and C,19 wich serve as linkers 
for different types of intermediate filaments14 Desmoplakin is the main linker protein between 
the cadherin–plakoglobin complex and the intermediate filaments.14 Experiments have shown 
that it may also be involved in regulating microtubule organisation.19
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Adherens junctions
Adherens junctions are found at the lateral surface of epithelial cells as well as sporadically along 
the surface of stratified squamous epithelial cells.21 Adherens junctions are composed of: 1) 
classical cadherins (such as E–, N– and P–cadherin), 2) armadillo proteins (such as β catenin and 
PG) and 3) cytoskeleton adaptor proteins (such as a catenin) (Figure 3).22
E–cadherin and P–cadherin are classical cadherins expressed in the epidermis. E–cadherin is 
expressed in all layers of the epidermis, whereas P–cadherin is only expressed in the basal cell 
layer. Adherens junctions are necessary for desmosome formation. PG and E–cadherin recruit 
plakophilin 3 a component of desmosomes to the cell border to start desmosome formation. 
Cross–talk exists between adherens junctions and desmosomes for the regulation of cell–cell 
adhesion in keratinocytes.23 Vasioukhin et al. describe the zipperfunction of adherence junctions. 
Neighbouring cells form filipodia which slide along each other and project into the opposing 
cell’s membrane. Embedded tips of filipodia are stabilized by puncta, which are transmembrane 
clusters of adherence junction proteins. Once initial filipodia embed, this anchorage seems to 
enhance the probability that additional filipodia will make functional contact, extending the zone 
of contact between two neighbouring cells. Desmosomes then form in the flanking regions of 
contact that are brought together by filipodia embedding.24 
Pathogenesis of pemphigus
Desmogleins as pemphigus antigens 
In 1964 Beutner and Jordan observed circulating antibodies directed against the cell surface of 
keratinocytes in the sera of patients with PV.25 Later it was demonstrated that autoantibodies 
in pemphigus are pathogenic and induce blister formation in skin organ culture systems26 and 
in neonatal mice.27 In 1982 Stanley et al. characterized the PV antigen at the molecular level by 
immunoprecipitation using cultured keratinocytes extracts as a substrate. All the PV sera iden-
tified a glycosylated 130 kDa glycoprotein.28 Two years later the PF antigen was characterized 
using immunoblot analyses of normal human epidermal extracts and demonstrated that about 
one–third of the PF sera identified a polypeptide of about 160 kDa. Later they showed that all 
PF sera bind to the 160 kDa glycoprotein.29
Koch et al. isolated a cDNA clone for Dsg1 from bovine muzzle epithelium and soon after-
wards cDNA for human Dsg1 from human stratified squamous epithelia or human cultured 
keratinocytes was isolated.30 In 1991 Amagai et al. isolated a cDNA clone for the PV antigen 
by immunoscreening a human keratinocytes expression library with autoantibodies prepared 
21Acantholysis in pemphigus / CHAPTER 1
from the sera of patients with PV. Analysis of the deduced amino acid sequences of the cDNA 
clones revealed the nature of pemphigus antigens. Both Dsg1 and PV antigen are cadherin type 
adhesion molecules that occur in desmosomes. PV antigen is termed Dsg3 because PV antigen is 
more closely related to Dsg1 than to other cadherins.31
Non desmoglein proteins as possible pemphigus antigens
Several studies suggested a role for target antigens other than desmogleins in pemphigus. 
Bedane et al. compared the localization of immune deposits in patients with PV and PF by 
both direct and indirect immunoelectron microscopy. They showed that in PV immune deposits 
were situated both on the extracellular part of the desmosomes and along large portions of the 
keratinocytes without desmosomal structures in most of the studied samples, while in PF the 
immune deposits were located on the extracellular part of desmosomes only. This led to the idea 
that the target antigen in PV is not always a component of the desmosomes but can also be a 
component of other focal adhesions.32 Later Nguyen et al. injected Dsg3–lacking mice with PV 
IgG that did not cross react with Dsg1 and observed suprabasal acantholysis and staining in a 
fishnet–like pattern. This led to the hypothesis that that mucocutaneous lesions in pemphigus 
could be caused by non desmoglein antibodies.33
Studies in mouse models showed that loss of Dsc3 leads to intra epidermal blistering.34 IgG 
directed against Dsc3 purified from Dsc3–reactive sera causes loss of adhesion of epidermal 
keratinocytes in vitro.35 Muller et al. studied the presence of IgG and IgA autoantibodies against 
Dsc1, Dsc2 and Dsc3 in a cohort of patients with bullous diseases and found that IgG and IgA 
reactivity against Dsc is restricted to cases of PNP, IgA pemphigus and atypical pemphigus.36
Besides being present in PNP, desmoplakin antibodies have also been found in PV,37 however 
these desmoplakin antibodies are probably caused by an epitope–spreading phenomenon.
Also antibodies directed against E–cadherin have been described in PF and PV although probably 
most of these antibodies cross react with Dsg1.38
Theories on the pathomechanism
The exact mechanism by which pemphigus IgG induces acantholysis has been a subject of 
debate since the discovery of pemphigus autoantibodies by Beutner and Jordan. Since then ac-
antholysis has been explained by several theories: 1) steric hindrance, 2) deranged cell signalling, 
3) impairment of desmosome assembly and increased desmosome disassembly
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Steric hindrance
One of the first concepts to explain acantholysis in pemphigus was “steric hindrance”. This 
theory is based on the idea that there is direct interference of pemphigus IgG with the amino–
terminal extracellular domain of desmogleins which form the trans–adhesive interface between 
keratinocytes. This concept is supported by several observations. Sekiguchi et al. described that 
the dominant autoimmune epitopes recognized by pemphigus antibodies are located in the 
amino–terminal adhesive region of desmogleins.39 Later it was shown that monoclonal anti- 
bodies directed against the amino–terminal adhesive region of Dsg3 induce a phenotype similar 
to mucosal-dominant PV in a mouse model.40 By electron microscopy split desmosomes were 
shown in the lesional mucosa of a PV mouse model41 and also in lesional skin of patients with 
mucocutaneous PV, mucosal-dominant PV and PF.42 Heupel et al. showed by using atomic force 
microscopy, that PV–IgG directly interferes with homophilic Dsg3.43
However, PF–IgG did not interfere with homophilic Dsg1 transinteraction.43 Later, the same 
group showed that PF IgG causes dissociation of Dsg1 containing junctions without blocking 
Dsg1 transinteraction.44 
Cell signalling 
Signalling pathways involving p38MAPK, RhoA, PKC, PG and c–myc have been shown to play 
a role in the pathogenesis of pemphigus. Also the pathways leading to apoptosis have been 
implicated to play a role in acantholysis.
P38 MAPK
There are three subfamilies of the mitogen activated protein kinases (MAPK): 1) p38, 2) ERK 
(extracellular signal–regulated kinase) and 3) JNK (c–jun amino–terminal kinase). The p38 
MAPK family members can be activated by environmental stress and regulate the expression of 
inflammatory cytokines.21
Berkowitz et al. observed that p38MAPK and heat shock protein 27 (HSP27) were rapidly 
phosphorylated after PV IgG binding to Dsg3 in human keratinocyte cell cultures. Inhibition 
of p38MAPK activity prevented PV IgG–induced HSP27 phosphorylation, keratin filament 
retraction and actin reorganization.45 Later they also showed phosphorylation of both p38MAPK 
and HSP25 (murine HSP27 homolog) in the skin of PF IgG–treated mice and that p38MAPK in-
hibitors prevent both PF and PV blistering in a mouse model system.46,47 The observations made 
in human keratinocyte cell cultures and mouse models were enforced by the finding of increased 
phosphorylation of p38MAPK and HSP27 in PF and PV patient skin.48 Jolly et al. later found that 
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p38 MAPK signalling and Dsg3–internalization are linked, as cell surface Dsg3 internalization 
and depletion from both detergent soluble and detergent–insoluble fractions were blocked by 
the p38 MAPK inhibitor.49
However, it is thought that p38 MAPK activation is probably secondary to the loss of intercellu-
lar adhesion. Mao et al. showed that PV monoclonal antibodies that do not dissociate keratino-
cytes because of compensation by Dsg1, do not activate p38. Whereas, the same monoclonal 
antibodies in combination with exfoliative toxin to inactivate Dsg1 but not exfoliative toxine 
alone activate p38 MAPK. Also mice with a targeted deletion of p38alfa in the epidermis show 
loss of intercellular adhesion after passive transfer of PV monoclonal antibodies. However, 
p38MAPK may function downstream to induce blistering trough Dsg3 endocytosis.50
RhoA
Rho, Rac and Cdc42 are some of the best known members of the family of over 20 known Rho 
small GTPases, which regulate mitosis, cytoskeletal reorganization, cell polarity, cell cycle regula-
tion, morphogenesis and cell migration. Rho family GTPases affect adherens junction assembly 
and disassembly through various pathways that regulate clustering of cadherin receptors on the 
cell surface, actin recruitment to junctions and endocytosis. Both Rho and Rac are required for 
the formation of adherens junctions with Rac localizing to new areas of intercellular contact.21
Waschke et al. suggested that PV IgG and PF IgG induce skin blistering by interference with 
RhoA signalling.51
Plakoglobin
A possible role for cell signalling involving PG was suggested from the observation that in kerati-
nocytes cultures from PG knockout mice incubated with PV IgG no keratin retraction and loss of 
adhesion was observed. However reintroduction of PG into the cells restored the responsiveness 
to PV IgG.52 The signalling cascade is started by binding of PV antibodies to Dsg3. This tempo-
rarily enhances the turnover of PG at the plasmamembrane and results in reduced availability of 
PG in the nucleus. As a result PG cannot function as a transcriptional repressor of the proto–on-
cogene c–myc, leading to accumulation of c–myc in the nuclei.53 C–myc inhibitors prevented 
formation of lesions induced by PV antibodies in the neonatal mouse pemphigus model.53 In 
patients there is a correlation between disease progression and regression and fluctuations in the 
levels of c–Myc.54
24 Acantholysis in pemphigus / CHAPTER 1
Apoptosis
Apoptosis is an important general principle to regulate tissue homeostasis and remodeling as 
well as protection against diseases such as cancer, infection and autoimmune disorders.55 The 
two main pathways of apoptosis are extrinsic and intrinsic. In the intrinsic pathway, increased 
expression of pro–apoptotic proteins as Bax, Bak, and Bim result in the increase of mitochon-
drial permeability and ﬁnally activation of caspases 3 and 6 leads to cell death. In the extrinsic 
pathway, activation of plasma membrane death receptors leads to reactions and ultimately gives 
rise to activation of executioner caspases 3 and 6. Eventually this results in the fragmentation of 
cellular DNA which can be evaluated by the TUNEL staining.56
While the morphological characteristics of apoptosis are not observed in hematoxylin and eosin 
(H&E) stainings of lesional pemphigus skin, evidence has been found for the role of apoptosis 
in the pathogenesis of pemphigus.55 Most evidence comes from studies that have shown an 
increased incidence of apoptosis by staining of TUNEL in perilesional,57 early lesional58 and 
lesional.59–61 PV skin. Also in cultured keratinocytes incubated with PV serum or IgG, TUNEL 
reactivity was observed.57,62,63 However, the TUNEL technique in detecting apoptosis is not 
speciﬁc and rarely stains necrotic cells as well. Also, apoptosis is not always associated with DNA 
fragmentation.56
Several studies also investigated proteins involved in the pathways of apoptosis. Lesional PV skin 
showed expression of Fas ligand, p53, Bax and activation of caspase 8.60 PV sera showed high 
levels of Fas ligand,57 and skin organ cultures incubated with pemphigus IgG showed activation 
of Fas ligand, Fas receptor and p53, and activation of caspase 1, 360 and 8.60,61 However, most 
studies were done in cultured keratinocytes.60–63, 64
Fewer studies have been done on apoptosis in PF skin, but evidence has been found for apop-
tosis in lesional PF skin.59,65 Acantholysis could be prevented by inhibiting apoptosis by adding 
anti–Fas ligand,57 caspase 1 inhibitor60 and caspase 8 inhibitor.57
There has been much debate about whether apoptosis is an early phenomenon, which leads 
to acantholysis or not. Most researchers believe that apoptosis occurs secondary to acanthol-
ysis.55,61–63 According to this point of view, acantholysis results in anoikis and later apoptosis 
occurs. Anoikis is the concept that loss of cell adhesion ends in apoptosis.56 Some researchers59,60 
believe that apoptosis is an early phenomenon which is related to acantholysis and probably 
there is a relationship between them, but it is not necessarily a causal relation. Recently the 
‘apoptolysis’ theory was proposed by Grando et al. that explains the functional relationship 
between apoptosis and acantholysis, which is mediated by the same set of cell death enzymes.66
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Assembly and disassembly
PV IgG leads to depletion of non–junctional Dsg3 in cell culture systems as shown by immuno-
blot and immunofluorescence.50,67–70 Non–junctional Dsg3 is depleted by endocytosis50,69 prob-
ably trough a dynamin– and clathrin–independent mechanism.71 Immuno–electron microscopy 
shows that the endocytosed Dsg3 is present in simple clusters without keratine intermediate 
filament attachment.72 Some researchers found that together with the loss of cell surface Dsg3 
there is also a loss of desmoplakin.50 Eventually, the depletion of non–junctional Dsg3 results in 
prevention of desmosome assembly. Mao et al. treated keratinocytes cultures with pathogenic 
PV monoclonal antibodies and observed less desmosomes by electron microscopy.50
Depletion of junctional Dsg3 is observed after 24–30 hours of incubation with PV IgG.50,70 In 
contrast to Aoyama et al., Mao et al. observed not only depletion of junctional Dsg3, but also of 
Dsc3 and PG. It is suggested therefore that prevention of Dgs3 incorporation into the desmo-
some leads to destabilization of the desmosomal structure, with subsequent turnover of various 
desmosomal molecules.50 Expression of exogenous Dsg3 using an adenoviral delivery system 
prevented the downregulation of Dsg3 and loss of adhesion in PV IgG treated cells.69
Besides binding of PV IgG to non–junctional Dsg3, it might also be possible that PV IgG binds 
to Dsg3 integrated in the core domain of desmosomes. This leads to exclusion from the desmo-
somes and possible internalization into endosomes.67
Unfortunately not much research has been done on the effect of anti–Dsg1 antibodies on 
desmosome assembly and disassembly. Cirillo et al. showed that anti–Dsg1 antibodies induced 
temporary internalization of Dsg1 and reduced the adhesion strength among keratinocytes.73 
However, binding of IgG to Dsg1 did not lead to early depletion from the adhesion complexes 
but reduced the amount of Dsg1 found in the Triton X–100 soluble pool of proteins.73,74
Diagnosis
The diagnosis of pemphigus is based on three criteria: clinical features, histopathological findings 
and immunological tests.
Clinical features
As mentioned above the classic clinical findings are multiple flaccid blisters on healthy skin and/
or multiple oral ulcers and a positive Nikolsky sign.4
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Histological findings
Pemphigus foliaceus
Blisters in PF are localized in the upper layers of the epidermis, within the granular or upper 
spinous layer (Figure 4a). As the blisters are superficial and fragile, it is often difficult to find an 
intact lesion for histological examination. Therefore, acantholysis is sometimes difficult to detect, 
but usually a few acantholytic keratinocytes can be found attached to the roof or floor of the 
blister. These superficial blisters are histologically indistinguishable from those seen in staphy-
lococcal scalded skin syndrome or bullous impetigo, because Dsg1 is targeted in both diseases. 
Sometimes the blister cavity contains numerous acute inflammatory cells, particularly neutro-




The characteristic histological finding in PV is an intraepidermal blister usually just above the 
basal layer (suprabasilar acantholysis) (Figure 4b). A few rounded–up acantholytic keratinocytes 
(acanthocytes) as well as clusters of epidermal cells are often seen in the blister cavity. Although 
the basal cells loose lateral desmosomal contact with adjacent keratinocytes, they maintain 
attached to the basement membrane via hemidesmosomes, thus giving the appearance of a row 
of tombstones. The acantholytic process may also involve the hair follicles. The dermal papillary 
outline is usually maintained and, often, the papillae protrude into the blister cavity. The blister 
cavity may contain a few inflammatory cells, notably eosinophils, and in the dermis there is a 
moderate perivascular mononuclear cell infiltrate with eosinophils.1
 
Figure 4 – Histopathology and immunofluorescence of cutaneous lesions in pemphigus. (a) Pemphigus foliaceus: intraepi-
dermal split at the level of the granular layer (hematoxylin and eosin (H&E)). (b) Pemphigus vulgaris: suprabasal acantholysis 
level with apico–lateral detached basal cells (‘tombstones’)(H&E)). (c) Direct immunofluorescence microscopy of pemphigus 
vulgaris: dotted or granular staining of IgG in an epithelial cell surface (ECS) pattern. 
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Desmoglein compensation theory
Mahoney et al. developed the desmoglein compensation theory for the explanation of the 
location (skin or mucous membranes) and level of blisters in pemphigus patients. This theory 
states that coexpression of Dsg1 and Dsg3 in keratinocytes protects against acantholysis due 
to antibody–induced dysfunction of Dsg1 or Dsg3 alone (Figure 5).75 In skin, Dsg1 is expressed 
throughout the whole epidermis, but more intense in the superficial layers. Expression of Dsg3 
is limited to the basal and suprabasal layers. In mucosa, Dsg1 is expressed in the superficial 
layers, while Dsg3 is expressed throughout the whole epidermis. According to the desmoglein 
compensation theory blistering in PF can be explained as follows: In PF, anti–Dsg1 antibodies 
cause blisters in the superficial epidermis only because in this area Dsg1 is present without 
coexpression of Dsg3. Although the Dsg1 antibodies bind to mucosa, no blisters are formed 
because of the coexpression of Dsg3. In mucosal-dominant PV, Dsg3 antibodies cause blistering 
of the mucous membranes only, because in skin there is sufficient Dsg1 present to compensate 
for Dsg3. In mucocutaneous PV there is suprabasal blistering of both the skin and the mucous 
membranes, as Dsg1 and Dsg3 cannot compensate for one another anymore.
Basal cell shrinkage hypothesis
Bystryn and Grando proposed the basal cell shrinkage hypothesis for acantholysis in PV. This 
hypothesis states that binding of pemphigus antibodies to basal keratinocytes causes changes 
in their cytoskeletal structure with consequent collapse and shrinkage of the cells. Keratinocytes 
separate because they shrink more than they can be held together by desmosomes and not 
because of a primary defect in the function of desmosomes. The shrinkage is limited to the basal 
cells because these cells are less rigid and shrink more readily when their cytoskeleton is altered 
than their suprabasal counterparts. The cytoskeletal structure of the basal cells is affected to a 
greater extent by the signalling event and/or a different set of signalling events is triggered.76
Immunological tests
All forms of pemphigus are associated with the presence of skin–fixed and circulating antibodies 
against keratinocytes cell surface antigens.2 
Direct immunofluorescence
Tissue–fixed intercellular antibodies are present in lesions and adjacent healthy skin in about 
90% of patients with pemphigus and are detected by direct immunofluorescence.2 These 
antibodies are very rare in other diseases and are more sensitive and specific for the diagnosis of 
pemphigus than circulating antibodies. They are usually IgG, but IgM and IgA with or without 
complement may also be deposited (Figure 4c).2
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Figure 5 – Desmoglein compensation hypothesis. (a) Normal distribution of desmoglein (Dsg)1 and Dsg3 in the epider-
mis and mucous membrane. (b) In pemphigus foliaceus, IgG directed against Dsg1 causes subcorneal blistering in skin 
because in the lower layers Dsg3 compensates for the loss of function of Dsg1. In mucosa however anti–Dsg1 antibodies 
do not cause blistering, because there is sufficient Dsg3 present throughout all the layers to compensate for Dsg1. (c) In 
mucosal-dominant pemphigus vulgaris (PV), IgG directed against Dsg3 does not cause blistering of the skin because Dsg1 
compensates for the loss of function of Dsg3. However there is suprabasal blistering of the mucous membranes because 
there is not sufficient Dsg1 present to compensate for Dsg3. (d) In mucocutaneous PV antibodies directed both Dsg1 and 
Dsg3 cause blistering of the skin and the mucous membranes. 
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Indirect immunofluorescence
Circulating intercellular antibodies are detected by indirect immunofluorescence assays of serum 
using human skin, monkey oesophagus or guinea pig oesophagus as a substrate. Circulating 
antibodies are present in about 80% of patients. There is a correlation between the titre of 
intercellular antibodies and the activity of the disease. Serial determinations antibody titres may 
be useful in guiding therapy, since a rise in their titre usually precedes a recurrence in disease 
activity, while they usually decrease with successful treatment and disappear in patients in 
remission.2
ELISA
Enzyme–linked immunosorbent assays (ELISA) are available to detect antibodies directed against 
Dsg1 and Dsg3. The presence of antibodies directed against Dsg3 sometimes together with 
those against Dsg1 is associated with PV, whereas antibodies directed against Dsg1 alone are 
associated with PF. ELISA kits are available with the ectodomain of desmoglein produced in 
insect cells or in human cells. The latter has the advantage of containing the mature protein only 
and not the proprotein as well.77 It is thought that pathogenic antibodies are directed against 
conformational epitopes only and these epitopes are present in the mature desmogleins, while 
non–pathogenic antibodies recognize both mature and proprotein isoforms, correlating with 
binding of nonconformational epitopes.78
 
Aims of the study
The aim of this thesis is to gain more insight into the pathogenesis of pemphigus by studying 
acantholysis in pemphigus patient skin using histology, immunohistochemistry and electron mi-
croscopy. Most investigators use in vitro cell models and mouse models to study the pathogen-
esis of pemphigus. In this thesis we will focus on patient biopsies and organ cultures of human 
skin. In chapter 2 we will give an overview of the human model systems that have been used in 
the past to study the pathogenesis of pemphigus. Furthermore we will discuss to what extent 
these models represent the in vivo situation and how suitable they are to study the pathogenesis 
of pemphigus. 
In chapter 3 we will describe the distribution of IgG and the desmosomal proteins in PF and PV 
patient skin. Chapter 4 will give a description of the ultrastructure of PF patient skin. We have 
used this old technique to look at pemphigus skin with the knowledge we have gained in the 
last decennium. In chapter 5 the differential effect of Dsg1 autoantibodies and Dsg3 autoanti-
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bodies on desmosomes is studied in a morphometric study on the different types of pemphigus 
patient skin. In chapter 6 we searched for evidence of apoptosis in pemphigus skin by immuno-
fluorescence and electron microscopy.
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Abstract
Background Pemphigus is a chronic mucocutaneous autoimmune bullous disease that is charac-
terized by loss of cell–cell contact in skin and/or mucous membranes. Past research has success-
fully identified desmosomes as immunological targets and has demonstrated that acantholysis is 
initiated through direct binding of IgG. The exact mechanisms of acantholysis, however, are still 
missing. Experimental model systems have contributed considerably to today’s knowledge and 
are still a favourite tool of research. 
Objective In this paper we will describe to what extent human cell and tissue models represent 
the in vivo situation, for example, organ cultures of human skin, keratinocyte cultures, and 
human skin grafted on mice and, furthermore, how suitable they are to study the pathogenesis 
of pemphigus. 
Conclusions Organ cultures closely mimic the architecture of the epidermis, but are less suitable 
to answer posed biochemical questions. Cultured keratinocyte monolayers are convenient in this 
respect, but their desmosomal make–up in terms of adhesion molecules does not exactly reflect 
the in vivo situation. Reconstituted skin is a relatively new model that approaches organ culture. 
In models of human skin grafted on mice, acantholysis can be studied in actual human skin but 
now with all the advantages of an animal model.
 
Introduction
Pemphigus is a chronic mucocutaneous autoimmune bullous disease, characterized by the 
presence of autoantibodies against the desmosomal cadherins, desmoglein (Dsg)1, and/or Dsg3. 
There are two main forms of pemphigus: pemphigus foliaceus (PF) and pemphigus vulgaris (PV). 
PF presents as superficial blistering of the skin and the presence of autoantibodies against Dsg1. 
In the case of mucosal-dominant PV, patients have suprabasal blistering of the mucous mem-
branes and autoantibodies against Dsg3 only. Patients with mucocutaneous PV have suprabasal 
blistering of both the skin and the mucous membranes, in combination with autoantibodies 
against both Dsg1 and 3. 
Since the discovery by Beutner and Jordon in the sixties, who demonstrated by indirect immuno-
fluorescence (IIF) microscopy that sera of PV patients contained IgG antibodies directed against 
a substance on the surface of keratinocytes,1 investigators have tried to answer an intriguing 
question: how do these antibodies cause acantholysis in skin? In the nineties, Mahoney et al. 
presented their theories on steric hindrance and desmoglein compensation2 as an explanation for 
acantholysis. Recently, researchers are also focusing on other putative mechanisms for example, 
cell signalling,3,4 apoptosis,5 desmosome assembly and disassembly,6 and endocytosis.7 
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Although the exact steps in the process of acantholysis in pemphigus are still not clear, research 
herein has considerably benefitted from experimental models, for example, mouse models and 
in vitro models. Unlike the animal models, the in vitro models have been used to study the 
effector–phase of pemphigus and not its cell–mediated immune regulation. In this paper we will 
discuss the in vitro models and focus on human cell and tissue models. These models comprise 
organ cultures of human skin, cultured human monolayer keratinocytes, reconstituted skin, 
and human skin grafted on mice. We will discuss how well these human cell and tissue models 
represent the in vivo situation in human skin and their suitability to study the pathogenesis of 
pemphigus.
Organ cultures of human skin
Michel and Ko were among the first who successfully produced acantholysis in vitro by using 
an organ culture model.8 They described a relatively simple and reproducible method based on 
the work of Sarkany et al.9 Michel et al. placed a skin explant on lens paper which floated on the 
surface of liquid that contained crude pemphigus serum. Since then, more research groups have 
used this organ culture model to study pemphigus.10–18 We ourselves have recently performed 
experiments using an organ culture model with air–liquid interface in which a biopsy of normal 
human skin is not floated on lens paper but instead placed on a transwell such that the bottom 
of the biopsy contacts the solution containing IgG (Figure 1). In a second approach we sub-
merged biopsies in solution. This enabled culturing more biopsies in one and the same volume 
of medium with added pemphigus IgG or Fab fragments. Biopsies can be easily harvested at any 
time and processed for light microscopy, immunofluorescence, or electron microscopy. Although 
submerged culturing induces shifts in the expression of the different cadherins, for example, 
substantial loss of Dsg1 and desmocollin (Dsc)1 with increased expression of Dsg3 in higher cell 
layers, this only manifests after prolonged culturing, and their expression remains comparable to 
normal human skin when the experiments are limited to 24 hours (Figure 2). 
Michel and Ko incubated normal human skin with undiluted sera from pemphigus patients. 
Direct immunofluorescence (DIF) showed intercellular staining of IgG. Light microscopy showed 
a split after 24–hours incubation. Unfortunately, this first attempt was not as successful as had 
been hoped and both PF and PV sera induced a suprabasal split.8 Later investigators, however, 
did succeed in producing correct subcorneal splits in normal human skin with PF IgG.16 In our 
own organ culture model subcorneal acantholysis can be induced not only by PF IgG but also by 
PF Fab fragments (Figure 1f). 
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Next to whole serum, Michel and Ko also performed incubations with heated serum in order 
to inactivate complement.8 Heated serum also led to acantholysis, which showed that the 
pathogenesis of pemphigus was not complement dependent.8,19,20 The demonstration that Fab 
fragments of pemphigus IgG also induce acantholysis confirmed the concept that complement 
fixation was not a necessary step in this disease.21 Acantholysis thus is independent of IgG 
subclass.
 
Figure 1 – Incubation of normal human skin with pemphigus IgG or Fab fragments leads to suprabasal or subcorneal acan-
tholytic blistering. (a) Normal human skin (NHS) before incubation. Incubation of NHS for 24 hours in (b) medium only or in 
medium with added (c) control Fab fragments or (e) control IgG leads to limited spongiosis of the epidermis. Incubation of 
NHS in medium with added (d) Pemphigus foliaceus (PF) Fab fragments and (f) PF IgG induces a subcorneal split. Incuba-
tion of NHS in medium with (g) Pemphigus vulgaris IgG induces suprabasal acantholysis.
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Figure 2 – Shift in expression of desmoglein (Dsg)1, desmocollin Dcs1, and Dsg3 in submerged skin cultures aftermore than 
24 hours. (a) Dsg1 is expressed throughout all the layers of normal human skin (NHS). (b) The expression of Dsg1 by skin 
incubated in medium for 24 hours is comparable to that of NHS. (c) After incubation in medium for 72 hours, Dsg1 expres-
sion is reduced. (d) Dsc1 is expressed in the upper layers of the epidermis. (e) The expression of Dsc1 by skin incubated in 
medium for 24 hours is comparable to that of NHS. (f) After incubation in medium for 72 hours, Dsc1 expression is reduced. 
(g) Dsg3 is expressed in the basal and suprabasal layers of the epidermis in NHS. (h) The expression of Dsg3 after incubation 
in medium for 24 hours is comparable to that of NHS. (i) After incubation in medium for 72 hours, Dsg3 is also expressed in 
the upper layersof the epidermis.
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Hu et al. studied the effects of pemphigus IgG incubation on normal human skin by electron 
microscopy.22 After 12–hours incubation the first changes, for example, intercellular widening, 
were seen. After 24 hours the intercellular widening had progressed, and dissolution of the 
desmosomes became visible. Also desmosome remnants could be seen on the surfaces of the 
keratinocytes; the tonofilaments had retracted from the cell periphery and were concentrated 
in a perinuclear position. After 72 hours a suprabasal split and widening between the basal 
cells (a row of tombstones) were seen.22 Most of the observations described by Hu et al. are 
comparable to those seen in pemphigus patient skin, but whether or not the observed retraction 
of tonofilaments in this organ culture model is comparable to the in vivo situation remains a 
matter of debate. Unlike others,23 we ourselves did not observe this retraction of tonofilaments 
in pemphigus patient skin.24 
The human organ culture model has been very valuable in obtaining information on the mech-
anisms of acantholysis and, moreover, has also been used to test old and new therapeutic drugs 
for pemphigus, for example, hydrocortisone,13 dapsone,13 methylprednisolone,17 and protease 
inhibitors.15 Although most popular in the eighties, it is still used today, often in combination 
with other models.16,25–28 The major advantage of skin explants remains that it is actual human 
skin with correct architecture of all epidermis layers. Layer–specific changes in morphology or 
protein localization can easily be studied by light microscopy, immunofluorescence, or electron 
microscopy. However, explants are less suitable to answer biochemical questions concerning 
molecular pathways, that is, the activation of receptor molecules or changes in phosphorylation 
state of pathway intermediates.
In contrast to cultured cells, cells in the skin explant reside in layers of varied differentiation that 
most likely respond differently to external stimuli. Aside from this, cultured cells will instanta-
neously make contact with the added IgG, while in organ cultures the IgG must diffuse into the 
epidermis and will not reach all cells simultaneously. Therefore, more easily manageable culture 
models are the preferred models for biochemical and molecular biological research on acanthol-
ysis.
Keratinocyte cultures
A year after the first publication on the organ culture model, Schiltz et al. incubated human 
keratinocytes with pemphigus IgG.29 The results of these experiments suggested that binding of 
pemphigus antibodies to the keratinocytes initiates a series of events which result in the release 
or activation of hydrolytic enzymes by the keratinocytes with subsequent autolysis and acanthol-
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ysis. This made it clear that keratinocyte cultures could serve as a model for acantholysis. Various 
sources of cells are now being used, with most researchers using normal human epidermal 
keratinocytes (NHEKs).30–32 These keratinocytes are often derived from neonatal foreskin6,7,28,33–37 
but can also be obtained from surgical excised skin.38 HaCaT cells, a nontumorigenic human 
keratinocyte cell line, are also popular.16,39–43 Less commonly used is the squamous cell carcinoma 
(SCC) cell line DJM–1.35,44
Cultured keratinocytes are mostly used as monolayers or alternatively as reconstituted skin. 
Keratinocytes grown in low calcium medium will proliferate until confluent and then become 
growth arrested. In high–calcium medium (1.2 mM or higher) cells will differentiate, form 
desmosomes, and stratify.45 For reconstituted skin, it is a requisite to culture the keratinocytes 
on a dermal equivalent.46 Varying the calcium concentration provides a tool to induce and study 
desmosome assembly and disassembly.6,45 Whether cultured keratinocytes are a reliable model, 
to study pemphigus pathogenesis, be it in the form of monolayers or reconstituted skin, will 
depend mainly on their ability to form mature desmosomes with correct make–up of cadherins 
and associated molecules. The expression and localization of the pemphigus antigens and other 
desmosomal adhesion molecules in cultured cells, therefore, became an early subject of research.
By IIF staining with patient sera it was shown that the PV antigen is expressed in human 
epidermal monolayers when cultured under high–calcium conditions, but at the same time these 
monolayers lack the PF antigen.47
Low–calcium cultured monolayer cells do not express Dsg147,48 and Dsg2,48 while high–calcium 
cultured monolayers express Dsg1.47 As shown by immunoblot, Dsg1 is detectable after 1 to 
6 days of culturing,48 but the expression levels appear to be low.33 As keratinocytes become 
stratified, Dsg1 expression increases and can be detected on the plasma membrane of stratified 
cells in a membrane–bound pattern.47 The Dsg2 expression in high–calcium cultured mono-
layers is only positive after 5–6 days as shown by immunoblot.48 Some groups report that the 
immunoblot does not show expression of Dsg3 by low–calcium cultured monolayers.48 Dsg3 
was detected in the cytoplasm of cells grown under low–calcium conditions while the protein is 
translocated to the plasma membrane when cultured under high–calcium conditions.6 Staining 
of Dsc3 in NHEKs cultured under low–calcium conditions shows a diffuse cytoplasmic and a focal 
desmosomal pattern, but comparable to Dsg3 the desmosomal staining intensifies after raising 
the calcium concentration.6
HaCaT cells are capable of expressing Dsg1, Dsg2, and Dsg3,43,48 and similar to normal keratino-
cytes, Dsg1 expression is induced by high levels of calcium.48
Most tested SCC cell lines have weak or focal intercellular expression of PV antigens and 
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expression of PF antigens in localized areas.47 Denning et al. tested several SCC cell lines and 
showed by immunoblot Dsg2 and Dsg3 expression by these cells when cultured in normal or 
high–calcium media.48 Aoyama and Kitajima used the DJM–1 cell line and showed expression of 
Dsg1 and Dsg3 when cultured in high calcium.49
Low calcium High calcium
Celtype Dsg1 Dsg2 Dsg3 Dsc3 Dsg1 Dsg2 Dsg3 Dsc3
NHEK - - - + ± + + +
HaCaT - + + + + +
SCC - - - + + +
Table 1 - Expression of desmosomal components by monolayers composed of different cell types cultured in low– or high 
calcium medium. – = negative, ± = weak positive, + = positive. 
From the information summarized in Table 1, we can conclude that NHEKs have limitations as 
an experimental model for pemphigus since these cells do not express significant amounts of 
Dsg1. Consequently, these experimental systems are not suitable to study acantholysis in PF and 
mucocutaneous PV. HaCaT cells and DJM–1 cells (Table 1), which express Dsg1 in monolayers, 
might be more appropriate model systems. It must be taken into account, however, that these 
cells might express Dsg250 that is not present in most skin areas affected by pemphigus. Despite 
all drawbacks, monolayers have contributed much to our knowledge on acantholysis and have 
been at the basis of new ideas and insights. An elegant practical example of their use is the 
in vitro keratinocyte dissociation assay that can quantify the anti–Dsg3 acantholytic effects of 
patient IgG7,32,33,42,44,51–53 After incubation of monolayers with IgG, dispase is used to release the 
cell sheet from the culture dish. This sheet is then subjected to fierce mechanical stress by means 
of pumping in and out of a syringe. The resulting number of cell fragments is a quantification of 
the acantholytic effect of the IgG.54 An illustration of just how important the cadherin composi-
tion of the desmosomes is becomes apparent when HaCaT cells are used in the same assay and 
no fragments are formed. This is likely due to the high Dsg2 expression.54
Keratinocytes cultured in reconstituted skin will differentiate and stratify. Therefore both PV and 
PF antigens are expressed in reconstituted skin.47,55–57 By culturing keratinocytes air–exposed on 
a dermal equivalent, it is possible to reconstruct a multilayered epidermis.46,58 The morphology 
of this reconstituted skin can be compared to that of epidermis in vivo.46,58,59 Ultrastructural 
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assessment of a skin equivalent showed mature desmosome formation.46,59 Unfortunately, the 
expression of the desmosomal proteins, the cadherin antigens, and the formation of desmo-
somes in these skin equivalents are not well documented. DIF or IIF of desmosomes showed 
intercellular staining, but in contrast to human skin, there is also strong staining at the top level 
or cornified layer.58,59 Few researchers used reconstituted skin as an in vitro model to study the 
pathogenesis of pemphigus.60–62
Human skin grafted on mice
As mentioned in the introduction, mouse models are often used in pemphigus research next to 
the human in vitro models. By using mouse models however, pemphigus is induced in murine 
skin which might differ in its function from human skin. By grafting human skin on mice, 
acantholysis can be studied in human skin while at the same time providing the researcher with 
the advantages of a mouse model.63 There is only limited experience with these mouse models 
in pemphigus. Zillikens et al. grafted full thickness human skin onto the back of SCID mice.64 
PF and PV IgG were injected in the dermis of the graft. Histopathologic findings and DIF of the 
grafted human skin were comparable to histopathologic findings and DIF in PF and PV patient 
skin. Others used reconstituted skin grafted onto SCID mice, and subcorneal blistering was 
induced by injection of PF IgG.27 These graft models therefore seem very promising.
Model comparison
When studying a human disease, a model is required that approaches the in vivo human situ-
ation as closely as possible. Studying the pathogenesis of pemphigus in patients unfortunately 
has its limitations. For ethical reasons, biopsies cannot be taken too often making it impossible to 
follow the time course of disease development in detail. Mouse models have given great insight 
into the disease, but mice are not completely comparable to humans, so some questions remain 
that will have to be addressed in human models. The human in vitro models described in this 
paper all have their advantages and disadvantages. Therefore no single model may be preferred, 
but different models may be used in a complementary fashion. Organ cultures and skin equiva-
lents have the advantage that they are most comparable to human skin in terms of desmoglein 
expression and mature desmosomes. Acantholysis can be evaluated easily with light microscopy, 
immunofluorescence or electron microscopy. To study pathways and to follow the fate of 
individual molecules in a narrow time frame in terms of expression level, shifts in localization, 
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phosphorylation, or molecular interaction, easily manageable culture models are favoured. Cell 
lines should be chosen such that they reflect the skin situation as closely as possible. As discussed 
before they are suitable to study aspects of acantholysis in PV but not PF for the simple reason 
that no cells so far have been cultured that express Dsg1 in absence of Dsg3. The mechanism 
of pemphigus acantholysis has been studied for the past forty years and has taught us which 
molecules are involved and that acantholysis occurs in the absence of inflammation mediators. 
How desmosomes split and what molecular pathways lead to acantholysis is still being debated. 
The use of different experimental models is required to investigate the patho–mechanism.
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Abstract
Background In pemphigus circulating IgG is present directed against the desmosomal cadherins 
desmoglein (Dsg)1 and Dsg3. In the epidermis of patients, this IgG deposits in a pattern that is 
often partly granular and does not reflect the normal Dsg distribution. 
Objective To understand why the IgG deposits in a granular pattern in the skin of patients with 
pemphigus.
Patients ⁄ Methods We analysed the distribution of IgG and desmosomal adhesion molecules in 
skin biopsies of 18 patients with pemphigus vulgaris (PV) and 10 with pemphigus foliaceus (PF) 
by double staining immunofluorescence. The effect of IgG on desmosomal proteins was studied 
in an in vitro skin model. 
Results In PF skin Dsg1, but not Dsg3, was aberrantly distributed in the same partly granular 
pattern as the IgG. Vice versa, in skin of PV patients with anti–Dsg3 antibodies, Dsg3, but not 
Dsg1, colocalized with the granular IgG. Plakoglobin (PG) also coclustered with IgG and Dsg, 
but this was far more prominent with Dsg1 than with Dsg3. In areas of heavy Dsg1 clustering, 
but not in areas of heavy Dsg3 clustering, intercellular widening between keratinocytes was 
present. Patient IgG, but not Fab fragments, induced the same Dsg clustering in vitro. 
Conclusions The IgG–induced clustering of the Dsg autoantigens underlies the granular IgG 
deposition in patient skin. In PF and in mucocutaneous PV, Dsg1 clustering, but not Dsg3 
clustering, correlates with nonacantholytic intercellular widening between desmosomes. In the 
patient the Dsg becomes sequestered from desmosomal components which fits in with the 
desmoglein nonassembly depletion hypothesis, indicating that targeted non-junctional Dsg is no 




Pemphigus is an autoimmune disease characterized by the intraepidermal deposition of IgG and 
blistering of skin and ⁄or mucous membranes. The two major types of pemphigus comprise pem-
phigus vulgaris (PV), always affecting mucosa and in approximately half of the cases skin, and 
pemphigus foliaceus (PF) that affects only skin. In PV the IgG against desmoglein (Dsg)3 causes 
suprabasal acantholysis, while in PF IgG against Dsg1 provokes subcorneal acantholysis.1–4
Desmogleins, belonging to the cadherin family, are desmosomal proteins that link keratinocytes. 
Two opposing desmogleins bind each other with the extracellular N–terminal domains. Their 
cytoplasmic domains bind plakoglobin (PG), which can bind desmoplakin (DP) that can link to 
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the keratin intermediate filaments. Dsg3 is more abundantly present in the lower epidermis, but 
absent in the upper layers, while Dsg1 expression increases from the basal to the granular layer. 
This differential distribution is the basis of the Dsg compensation hypothesis that explains the 
difference in separation levels between PV and PF by Dsg isoform redundancy.5,6
The mechanism by which IgG induces acantholysis remains a matter of debate. Four concepts 
prevail currently: (i) binding of IgG to junctional Dsg disrupts homophilic transinteraction, 
leading to lengthwise splitting of desmosomes and loss of cell–cell adhesion (steric hindrance 
hypothesis);7 (ii) binding of IgG to non-junctional Dsg disturbs intracellular signalling pathways 
ending with cytoskeleton collapse or desmosome disassembly (cell signalling hypothesis);8–12 (iii) 
binding of IgG induces loss of junctional Dsg3 from desmosomes from endocytosis and dis- 
mantling of the desmosomes (disassembly depletion hypothesis);13 and (iv) binding of IgG 
induces endocytosis of the non-junctional Dsg3 pool which stagnates the assembly of Dsg into 
desmosomes (nonassembly depletion hypothesis).13,14 Supportive evidence is present in the 
literature for all concepts and underlines the vast complexity of investigating the pathogenic 
process of acantholysis.
Most of today’s concepts originate from experimental models; relatively little attention has been 
given to patient skin. Those who perform diagnostic immunofluorescence microscopy know that 
there is a strange discrepancy between in vivo IgG deposition by direct immunofluorescence 
(DIF) on patient skin and the intercellular substance (ICS) pattern by indirect immunofluo-
rescence (IIF) that is described as typical for pemphigus. The ICS pattern is a smooth staining 
around the epidermal cells, also called honeycomb or chicken wire pattern, and is consistent with 
the normal distribution of the desmogleins. In patient skin however the IgG deposits are often 
partly granular, especially in the lower layers.15 The reason for this is unknown, but could be 
related to the clumping of desmosomal components, which has been described for pemphigus, 
but not for the other acantholytic skin diseases.16,17 In drug–induced pemphigus the absence of 
such a patchy pattern is considered an indicator of good prognosis.18
In the present study we investigated multiple patient skin biopsies in order to understand why 
the IgG is deposited in vivo in such an aberrant granular fashion, and whether the granular 
deposition is connected with changes in cell morphology and acantholysis.
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Materials and methods
Patient samples
Forty biopsies of 28 patients with pemphigus, three mucosal-dominant PV, 15 mucocutaneous 
PV and 10 PF, were included. Biopsies were immediately frozen in liquid nitrogen and stored at 
-80°C. All diagnoses were based on clinical criteria and laboratory data, including histology and 
immunofluorescence. The anti–Dsg antibody profiles were determined by Dsg1 and Dsg3 en-
zyme–linked immunosorbent assays (ELISA) (MBL, Nagoya, Japan). The site of biopsy included 
lesional and ⁄ or non-lesional skin. Skin was considered non-lesional if it seemed healthy on 
physical examination and Nikolsky’s sign was negative. Biopsies from redundant breast reduction 
skin served as healthy controls. Electron microscopy was performed for two glutaraldehyde–
fixed biopsies, from Nikolsky-negative (N-) skin of a patient with mucosal-dominant PV and 
from Nikolsky-positive (N+) skin of a patient with PF. For the in vitro studies four PF and four 
mucocutaneous PV sera were used.
Purification of IgG and generation of Fab fragments
IgG was purified by HiTrap protein G sepharose chromatography (GE Healthcare, Uppsala, 
Sweden) according to the manufacturer’s protocol. Purified IgG was divided into two equal frac-
tions. One fraction was dialysed against phosphate buffered solution (PBS) (10 mmol L-1 sodium 
phosphate, 150 mmol L-1 NaCl, pH 7.2) and concentrated to 0.5 mL by ultrafiltration (Amicon 
Ultra 100K NMWL; Millipore, Co Cork, Ireland). From the second fraction Fab fragments were 
prepared using immobilized papain (Pierce, Rockford, IL, U.S.A.) according to the manufacturer’s 
protocol. The Fab fragments were separated from the undigested IgG and the Fc–tail by HiTrap 
protein A sepharose chromatography (GE Healthcare). The flow–through containing the Fab 
fragments was concentrated (Amicon Ultra 30K NMWL) to 0.5 mL. Both the IgG and Fab were 
mixed with 3 mL DMEM ⁄HAM 1 : 3 medium containing 2 mmol L-1 glutamine, 100 µg mL-1 
penicillin and 100 U mL-1 streptomycin and were stored at -80°C.
In vitro model
Six–millimetre biopsies from redundant breast reduction skin were placed on transwell inserts in 
a 24–well plate (Corning, New York, NY, U.S.A.). The IgG and Fab fractions were added to the 
wells, such that the medium contacted the bottom of the insert, and the plate was incubated 
at 37°C under cellculture conditions. After 24 h the biopsies were taken out, briefly rinsed with 
Hank’s balanced salt solution (HBSS) (Gibco, Glasgow, U.K.), frozen in liquid nitrogen and stored 
at -80°C.
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Immunofluorescence microscopy
The procedures for immunofluorescence staining and image collection have been described 
before in detail.19 The following monoclonal antibodies were used: Dsg1–P23 and 27B2 (Dsg1), 
10G11 (Dsg2), Dsg3–G194 (Dsg3), U100 [desmocollin 1 (Dsc1)], U114 (Dsc3), 15F11 (PG), 
DP2.15 (DP), PKP3–270.6.2 [plakophilin 3 (PP3)], NCH–38 (E–cadherin), 9G2 (ß–catenin) and 
HD121 (plectin). Double staining of deposited IgG and adhesion molecules was performed 
with fluorescein–conjugated Fcγ–specific goat Fab’2 antihuman IgG (Protos Immunoresearch, 
Burlingame, CA, U.S.A.) and Alexa 568–conjugated goat antimouse IgG (Molecular Probes, 
Eugene, OR, U.S.A) as secondary steps. For Fab fragments, we used fluorescein–conjugated 
rabbit antihuman light chain kappa and lambda Ig (DakoCytomation Denmark, Copenhagen, 
Denmark). For double staining with two different mouse monoclonal antibodies we used Zenon 
Mouse IgG Labeling kits Alexa Fluor 488 and Alexa Fluor 568 (Molecular Probes – Invitrogen, 
Eugene, OR, U.S.A.) following protocols from the company.
Electron microscopy
The biopsies were fixed in 2% glutaraldehyde and postfixed with 1% osmium tetroxide and 
1.5% potassium ferrocyanide in 0.1 mol L-1 sodium cacodylate buffer. After dehydration in alco-
hol they were embedded in epon and ultrathin sections were cut. These were stained with uranyl 
acetate and lead citrate and examined with a Philips CM100 transmission electron microscope 
(Philips ⁄FEI Corp., Eindhoven, Holland).
Results
All biopsies had intraepidermal deposition of IgG. This IgG did not have the overall smooth 
ICS distribution that is seen when pemphigus serum is brought on to a section of normal skin. 
Although some depositions at first glance had a smooth appearance, a closer examination re-
vealed some additional condensed IgG clumps or clusters, especially in the lower layers. In most 
biopsies this clustering was more apparent giving the overall pattern an irregular, somewhat 
speckled or punctate, appearance. Sometimes the IgG was present as interrupted lines but more 
often it had concentrated in a limited number of fine or coarse clusters per individual cell. We 
next investigated the distribution of desmosomal and non-desmosomal adhesion molecules.
Clustering of IgG, Dsg3 and plakoglobin in the non-lesional skin of patients with 
mucosal-dominant pemphigus vulgaris with IgG to Dsg3 only
The normal smooth ICS distribution of Dsg1 and 3 in healthy human control skin is shown in 
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Figure 1a–c. In the skin of a patient with mucosal-dominant PV, i.e. skin that has never blistered, 
Dsg3 had lost its normal smooth distribution and was clustered, while Dsg1 was still present in 
a normal smooth pattern (Figure 1d–f). Desmocollin (Dsc)3 (Figure 1g–j) and Dsc1 (not shown) 
also remained smoothly distributed. The overall Dsg3 fluorescence intensity was reduced com-
pared with normal human skin. IgG in vivo deposits colocalized with the clustered Dsg3 (Figure 
1j–l). The plaque proteins DP, PP3 and plectin remained smoothly distributed (Figure S1a). PG 
was largely normal but some slight concentrations followed the Dsg3 clusters (Figure 1m–o). 
The distribution of the adherens junction proteins such as ß–catenin remained smooth (Figure 
S1j–l). Clustering of in vivo deposited IgG can thus be explained by an altered distribution of 
IgG–bound Dsg3.
Clustering of IgG, Dsg1 and plakoglobin in the skin of patients with pemphigus foliaceus with 
IgG to Dsg1 only
In PF skin the IgG deposits were clustered in the lower layers and were mostly smoother in 
the higher layers, although in incidental biopsies the IgG had an almost completely punctuate 
appearance (Figure S2b,c). When a blister was present the punctuate deposits were most often 
located underneath it, although sometimes they were also seen above it (Figure S2d,e). A few 
biopsies had little IgG deposition and here puncta of IgG were only seen in the lower half of the 
basal cells (Figure S2a). Compared with mucosal-dominant PV skin the puncta had a coarser 
appearance. Both Dsg1 and PG heavily colocalized with the IgG clusters (Figure 2a–c). The 
other desmosomal cadherins remained normally distributed (Figure 2d–l). In areas of heavy PG 
clustering some concentration of other plaque molecules was visible. Figure 2m–r shows that DP 
and PP3 to some extent follow their binding partner PG. Adherens junction proteins E–cadherin 
and ß–catenin did not aggregate (Figure S1m–r).
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Figure 1 – Distribution of IgG and desmosomal adhesion molecules in healthy skin of patients with pemphigus vulgaris 
(PV) with IgG antibodies to desmoglein (Dsg)3. Double immunofluorescence staining (c, f, i, l, o are overlays from the reds 
and greens in the panels to the left of them) shows a punctate epidermal distribution of Dsg3 (Dsg3–G194) in the skin of a 
patient with PV (d, g, j, m) that contrasts with the Dsg3 distribution in normal human skin (a). The Dsg3 dots colocalize with 
the IgG (k) that is deposited in the same PV skin. Other cadherins such as Dsg1 (Dsg1–P23) (e) do not concentrate in these 
puncta and remain distributed as in normal human skin (b). Also desmocollin (Dsc)3 (U114) (h) does not follow the Dsg3. 
Some plakoglobin (PG–15F11) (n) colocalizes with the Dsg3 puncta. All images have the same magnification. The white bar 
is 40 μm.
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Figure S1 – Distribution of desmosomal plaque and adherens junction molecules in healthy skin of patients with pemphi-
gus vulgaris (PV) and pemphigus foliaceus (PF). In PV skin no colocalization with the Dsg3 dots (Dsg3–G194) (a, d, g, j) is 
seen for other desmosomal plaque molecules proteins desmoplakin (Dp2.15) (b), plakophilin–3 (PKP3–270.6.2) (e), plectin 
(HD121) (h) or with adherens junction molecules as shown here for ß–catenin (9G2) (k). Also in PF skin the adherens junc-
tions molecules E–cadherin (NCH–38) (n) and ß–catenin (9G2) (q) do not colocalize with the puncta represented here by the 
deposited IgG (m, p). Images c, f, i, l, o, r are overlays from the reds and greens left of them.
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Figure S2 – IgG deposition patterns in skin of a patient with pemphigus foliaceus (PF). Immunofluorescence demonstrated 
different IgG deposition patterns in the skin of a patient with PF. In skin with little IgG deposition (a) punctate aggregation 
was already present, but close to the basement membrane zone (BMZ) (white arrows). Other samples showed more intense 
IgG deposition that could be punctate in lower cell layers and smoother in upper cell layers (b, d) or punctate all over (c, e). 
This was observed in both non-lesional (b, c) and lesional skin (d, e).
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Figure 2 – Distribution of desmosomal adhesion and plaque molecules in skin of patients with pemphigus foliaceus (PF). 
Double immunofluorescence staining of PF patient skin reveals a dotted epidermal distribution of desmoglein (Dsg)1 (27B2) 
(a, d, g, j, m, n). The distribution of the plaque molecule plakoglobin (PG) (PG–15F11) (b) follows that of Dsg1 and is pres-
ent in the same dots. The other cadherins desmocollin (Dsc)1 (U100) (e), Dsc3 (U114) (h) and Dsg3 (Dsg3–G194) (k) do 
not follow the rearranged Dsg1. The plaque proteins desmoplakin (DP2.15) (n) and plakophilin–3 (PKP3–270.6.2) (q) partly 
concentrate at the same locations as PG and Dsg. Images c, f, i, l, o, r are overlays from the reds and greens in the panels to 
the left of them. All images have the same magnification. The white bar is 40 μm.
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Clustering of IgG, Dsg1, Dsg3, and plakoglobin in the skin of patients with mucocutaneous 
pemphigus vulgaris with IgG to Dsg1 and Dsg3
As expected both types of clusters were present in skin of patients with IgG to both Dsg1 and 
3. Although some aggregates were dominantly of the IgG ⁄Dsg3 ⁄PG type and some of the IgG/
Dsg1/PG type, they were usually concentrated at the same positions. The degree of clustering 
of the individual desmogleins could differ widely between patients. Patients with relatively high 
circulating anti–Dsg1 IgG as shown by ELISA values demonstrated heavier Dsg1 clustering, 
whereas anti–Dsg3 clustering dominated in patients with higher anti–Dsg3 ELISA values (Figure 
3a–d). This was reflected in the degree of PG clustering. PG was severely more reallocated by 
anti–Dsg1 than by anti–Dsg3 clustering (Figure 3e–f shows Dsg3 vs. PG).
Intercellular widening of the lower layers in the non-lesional skin of patients with pemphigus 
foliaceus and mucocutaneous pemphigus vulgaris, but not in the skin of those with 
mucosal-dominant pemphigus vulgaris
To investigate if clustering of Dsg leads to altered cellular morphology we stained our biopsy 
sections with haematoxylin and eosin (H&E). Skin with clustered Dsg3 did not show any 
abnormalities (Figure 4a). In PF skin with profound Dsg1 clustering, the keratinocytes exhibited 
subtle widening of the ICS, especially between basal cells and to a lesser degree between the 
suprabasal cells (Figure 4b). In lesional skin widening also extended to higher layers. The inter-
cellular widening roughly correlated with the degree of Dsg1 clustering. Biopsies without visible 
widening had little IgG deposition and minimal Dsg1 clustering. Intercellular widening was also 
present in the uninvolved skin of patients with mucocutaneous PV with additional antibodies to 
Dsg1, and whose skin demonstrated substantial Dsg1⁄PG aggregation (Figure 4c), but this was 
not seen in the skin of those with mucosal-dominant PV who lacked anti–Dsg1 antibodies. 
Additional electron microscopy confirmed these observations. Intercellular widening was present 
in the basal cell layer of a N+ PF skin biopsy, but not in mucosal-dominant PV skin although the 
corresponding immunofluorescence freeze biopsy demonstrated clustered Dsg3 (Figure 4d,e). 
Moreover the desmosomes in mucosal-dominant PV skin were of normal size and number (see 
the insert in Figure 4e). Therefore, clustered Dsg does not represent piled up floating desmo-
somes, which we initially thought, but represents complexes of IgG–bound non-junctional Dsg.
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Figure 3 – Distribution of desmoglein (Dsg)1, Dsg3 and plakoglobin (PG) in skin of patients with IgG to both Dsg1 and 
Dsg3. Both Dsg1 (27B2) (b, d) and Dsg3 (Dsg3–194) (a, c, e, g) become rearranged. The extent to which individual cad-
herins become concentrated in puncta differs between patients and seems to correlate with their respective anti–Dsg titres. 
Images a, b and e, f are from a patient with ELISA index values of 249 for Dsg1 and 126 for Dsg3 and images c, d, g, h 
from a patient with index values of respectively 88 and 301. PG (15F11) (f, h) did not follow the distribution of Dsg3 (e, g), 
but clustered with similar intensity as Dsg1 [compare image (b) with (f) and (d) with (h)]. All images were obtained through 
double staining and were photographed in separate channels, thus reds and greens represent the same section. The white 
bar is 40 μm.
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Figure 4 – Intercellular widening of the lower layers in skin of patients with antibodies to desmoglein (Dsg)1. Haematoxylin 
and eosin–stained sections of non-lesional skin of a patient with mucosal-dominant pemphigus vulgaris (PV) with IgG to 
Dsg3 only (a), of non-lesional skin of a patient with pemphigus foliaceus (PF) (b) and of non-lesional skin of a patient with 
mucocutaneous PV with IgG antibodies to both Dsg1 and Dsg3 (c). Subtle intercellular widening of the intercellular space 
is seen in the skin of the patients with PF and mucocutaneous PV, but not in the skin of the patient with mucosal-dominant 
PV. Electron microscopy demonstrates intercellular widening in N+ non-lesional PF skin (d) but not in non-lesional muco-
sal-dominant PV skin (e). Despite Dsg3 depletion the desmosomes in non-lesional mucosal-dominant PV skin are of normal 
size [higher magnification insert in (e), the bar is 500 nm]. The asterisk denotes the dermal compartment.
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Figure S4 – The rearrangement of Dsg and plakoglobin (PG) into clusters is induced by IgG from a patient with pemphigus. 
When biopsies of normal human skin were incubated with pemphigus foliaceus (PF) IgG (b, d, f) the IgG (b) became bound 
in the epidermis in a similar granular pattern to that observed in patient’s skin. Both Dsg1 (Dsg1–P23) (d) and plakoglobin 
(PG) (15F11) (f) rearranged into these same clusters. When incubated with normal human IgG (a, c, e) the IgG (a) was not 
bound in the epidermis and redistribution of Dsg1 (c) or PG (e) did not occur. All images have the same magnification. The 
white bar is 40 μm.
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Figure S3 – IgG and Fab fragments both induce the typical pemphigus blisters. Normal human skin biopsies incubated with 
pemphigus IgG or Fab fragments demonstrated blistering identical to that observed in pemphigus patient skin. Shown are 
the typical pemphigus vulgaris (PV) suprabasal blister that was induced with PV IgG (b) and the subcorneal pemphigus 
foliaceus (PF) blister that was induced here with PF Fab fragments (d). Control incubations with normal human (NH) IgG (a) 
or normal human Fab fragments (c) did not show blistering or acantholysis.
 
Figure 5 – IgG but not Fab fragments induce clustering. In skin that was incubated with pemphigus foliaceus (PF) IgG the 
plakoglobin (PG) (15F11) aggregated (a), while in contrast in skin that was incubated with Fab fragments prepared from the 
same IgG the PG did not become affected (b). Nevertheless the Fab fragments induced blistering at the subcorneal level. 
Both images have the same magnification. The white bar is 40 μm.
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Native pemphigus IgG, but not its Fab fragments, induce the typical desmoglein clustering in 
skin.
In vitro incubation of normal human skin with purified native PV–IgG and PF–IgG induced 
respectively suprabasal and subcorneal blistering. The IgG became bound in the epidermis in 
the same punctate pattern as in biopsies from patients (Figure S4b). Likewise, the targeted 
Dsg clustered, and PG co–clustered with the IgG (Figure S4d,f). Typical pemphigus blistering 
was also reached when the Fab fragments of these sera were used (Figure S3a–d). However, 
Fab fragments bound smoothly around the cells and clustering of Dsg or PG was not observed 
(Figure 5). The clustering of Dsg therefore results from an intrinsic characteristic of the IgG. 
The difference between IgG and Fab fragments is that the IgG is bivalent and able to crosslink 
desmogleins, in contrast to the monovalent Fab fragments. Clustering of IgG therefore is an 
indicator for the targeted Dsg, but not necessary for the pathogenesis of acantholysis.
 
Discussion
Here we show that clustering of IgG in the skin of patients with pemphigus is explained by the 
complex formation of non-junctional Dsg to which the IgG is directed. The in vitro experiments 
showed that this clustering is caused by crosslinking of Dsg by bivalent IgG. The ability of IgG 
but not of Fab fragments to crosslink Dsg has been reported before.20 The clusters do not result 
from acantholysis nor do they indicate active acantholysis. Instead they reveal that the targeted 
non-junctional Dsg becomes sequestered from desmosomal components. This fits the present 
experimental data that predict that IgG–bound soluble Dsg is not incorporated into desmosomes 
anymore, but leads to the disturbed assembly and desmosomal depletion of Dsg. 
In the skin of our patients with anti–Dsg3 antibodies the Dsg3 was present in a punctate 
pattern and at a reduced level. This decrease is in line with the observation that less Dsg3 
than normal can be extracted from pemphigus skin.21 Also in cultured cells PV–IgG initiates a 
decrease of Dsg3. First non-junctional Dsg3 disappears and next, as no replacement Dsg3 is 
now available to the desmosomes, desmosomal Dsg3 also disappears, leaving Dsg3–depleted 
desmosomes.13,14,21–23 This suggests that Dsg1 can fully compensate for Dsg3–depletion and 
preserves the size and number of the desmosomes in the basal cells of mucosal-dominant PV 
skin. Immunoelectron microscopy demonstrated that newly formed half–desmosomes were 
depleted of Dsg3, but not of Dsc3 by mucosal-dominant PV serum.24 Our data from the skin 
of patients favour this depletion hypothesis, as Dsg3 did not anymore colocalize with the other 
desmosomal cadherins. Importantly, however, this disorganization and depletion happens in skin 
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that, despite being loaded with IgG, does not show any signs of acantholysis or pre–acanthol-
ysis. Our patients with pure mucosal-dominant PV had oral lesions, thus their IgG was patho-
genic. At the same time they had healthy nonblistering skin that was not susceptible to minor 
trauma or friction and Nikolsky’s sign could not be evoked. This contrasts with experiments with 
cell monolayers that demonstrated decreased mechanical–stress resistance after Dsg3 depletion, 
which suggested that Dsg3–depleted desmosomes would result in fragile N+ skin.14,25 Our study 
of patients’ skin instead demonstrates that epidermis is able to withstand the pathogenic effects 
of the anti–Dsg3 antibodies and compensates for Dsg3 depletion. 
In PF skin, Dsg1 clusters instead of Dsg3. From the biopsies a picture emerges of an aggregation 
process that starts low in the basal layer, close to the basal membrane zone and that, when more 
IgG becomes available, also spreads to the layers above. That the basal layer shows the earliest 
change is not surprising as that layer contacts the IgG that enters from the dermis first. Other 
cadherins do not reallocate and this suggests, in analogy with Dsg3 depletion in PV, that in PF 
desmosomes become depleted of Dsg1. PF blisters never occur in the lower layers, thus suffi-
cient compensation is present to prevent the lower cells from becoming acantholytic, although 
intercellular widening is present, as will be discussed below. Further electron microscopy studies 
are necessary to answer the question whether PF desmosomes in basal cells become hypoplastic. 
A striking difference between PV and PF skin is the extent to which PG coclusters. Where in 
mucosal-dominant PV skin PG largely maintains its normal distribution it becomes markedly 
disturbed in PF skin and is seen as large dots colocalizing with Dsg1. The reason for this is not 
clear, but could be that PG is more tightly bound to Dsg1 than to Dsg3. The actual strength 
of binding of both cadherins with PG is unknown, but stoichiometric analysis of PG–cadherin 
complexes revealed that Dsg3 binds one molecule of PG where Dsg1 binds two.26 An alternative 
explanation involves the phosphorylation state of Dsg. Dsg3 becomes phosphorylated when 
IgG binds to it after which PG dissociates from Dsg3.27,28 28 The sequestering of IgGbound Dsg3 
therefore may have little effect on PG. For Dsg1 it is currently unknown if binding of IgG results 
in similar phosphorylation and dissociation, but our patient skin data suggest that this might not 
be the case in view of the coclustered Dsg1 and PG. 
The intercellular widening in the lower layers correlates with clustering of Dsg1. Widening is 
also seen when the expression level of Dsg1 is lower than normal. Haploinsufficiency of DSG1 
in palmoplantar keratoderma gives a similar widening of intercellular spaces.29 Furthermore 
silencing of the Dsg1 expression in human raft cultures also induces intercellular widening.30 
Dsg1 therefore might have an important role in keratinocyte cell–cell apposition in the lower 
epidermis. 
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It is without doubt, however, that in PF skin widening is present in layers where no acantholysis 
takes place. Ultrastructural studies of PF skin are in line with our observations. Wilgram et al.31 
observed widening between basal cells that they described as ‘early acantholysis’. Injecting 
IgG from endemic PF patients into mice results in early widening of interdesmosomal areas of 
the basal and spinous layer.32 In this respect it is interesting that interdesmosomal widening is 
also seen in PV skin, and after injecting PV serum into mice.33,34 Based on these observations 
intercellular widening is considered a pre–acantholytic event in PV, which also has initiated 
alternative theories involving basal cell shrinkage as a cause for acantholysis.35 It is, however, 
important to realize that these ultrastructural studies date back to the time when the antibody 
specificity of patients was not known and, considering the fact that they probably were patients 
with mucocutaneous PV having both anti–Dsg3 and anti–Dsg1 antibodies, it is conceivable that 
the early widening in mucocutaneous PV is caused by the concomitant anti–Dsg1 antibodies. A 
definitive answer can only be provided by repeating the electron microscopy studies with a series 
of defined patient samples. 
How do our findings on patient skin agree with current hypotheses on PV acantholysis? In 
view of the sequestering and decreased Dsg3 level in uninvolved skin, we do not doubt that 
the selective depletion of Dsg3 from desmosomes that has been repeatedly demonstrated in 
experimental cell systems, is also present in patients’ skin. The data therefore do not favour 
steric hindrance within desmosomes where no sequestering is expected, but do not exclude the 
possibility of steric hindrance in non-desmosomal Dsg. They also question the cell–signalling 
hypothesis. If PV–IgG induces acantholysis by activating the p38MAPK pathway then basal and 
suprabasal skin cells of anti–Dsg3 mucosal-dominant PV patients should become acantholytic, 
which contrasts with our observations. Nevertheless, cell signalling might have a place in the 
sequelae after intercellular widening has occurred from IgG binding. In the disassembly depletion 
hypothesis it is suggested that the antibodies interfere with desmosomal Dsg leading to internal-
ization of Dsg and dismantling of the desmosome. Although this mechanism is probably present 
it is not crucial in our vision, but rather secondary to the nonassembly depletion. Moreover, 
under normal homeostatic conditions desmosomes are also subject to dynamic turnover and 
it is questionable if IgG binding makes a difference here.36,37 Knowing the binding of IgG to 
soluble Dsg pools found by Aoyama et al.14 and the early non-desmosomal widening between 
epidermal cells in pemphigus,38 we favour from our patient data the nonassembly Dsg depletion 
hypothesis of desmosomes as also suggested by Payne’s group.22 We however expand this 
model with Dsg1 depletion based on our observations that Dsg3–depleted patient skin is sturdy, 
N- and ultrastructurally undisturbed. The compensatory mechanisms in skin are evidently of 
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such strength that they prevent skin from becoming N+. Based on our observations on PF skin, 
which suggest that anti–Dsg1 antibodies deplete desmosomes of Dsg1, we hypothesize that in 
mucocutaneous PV skin concomitant Dsg1 depletion will further weaken desmosomes leading 
to N+ and finally to acantholytic skin (Figure 6). Such a view is in line with desmosomes being 
dynamic structures that are continuously renewed, partly by the formation of completely new 
desmosomes, partly by replacement of molecules in existing desmosomes.36,37 Newly synthesized 
cadherins are transported from the Golgi to the membrane and form floating patches destined 
for incorporation into desmosomes. Frustration of this process by pathogenic IgG will rapidly 
lead to desmosomes becoming depleted of essential cadherins.
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Figure 6 – Conceptual model of pemphigus IgG–induced desmosomal depletion of desmogleins. (a) Under normal homeo-
static conditions desmosomal proteins are continuously renewed. Freshly synthesized desmogleins (Dsg1 in yellow, Dsg3 in 
blue) are transported from the Golgi apparatus to the membrane where they become present as non-junctional Dsg. It is still 
unknown whether this non-junctional Dsg is also involved in intercellular binding. Desmogleins are in continuous turnover in 
the desmosome and will be discarded by cellular uptake to be destroyed or recycled (right side desmosome), and replenished 
by fresh non-junctional Dsg (left side desmosome). (b) Selective depletion of the desmosome occurs when patients have IgG 
(red) to one Dsg isoform. This Dsg now becomes crosslinked by the IgG before entering the desmosome and will assemble 
in clusters outside the desmosomes. This leaves desmosomes that are depleted of one Dsg isoform but that are still able 
to resist acantholysis. (c) When both Dsg isoforms become crosslinked into clusters (red and green IgG) then desmosomes 
will not be able to renew themselves properly any more and, as they are subject to the same protein turnover as normal, 
will melt away because of lack of fresh replacement molecules. Without desmosomes, cells do not have sufficient adhesive 
properties and acantholysis will occur.
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Abstract
Background Pemphigus foliaceus (PF) is a chronic cutaneous autoimmune blistering disease that 
is characterized by superficial blistering of the skin, and according to the current perspective is 
caused by autoantibodies directed against desmoglein (Dsg)1.
Objectives To examine early acantholysis in the skin of patients with PF at an ultrastructural
level.
Patients/ Methods Two Nikolsky–negative (N-), five Nikolsky–positive (N+) and two lesional 
skin biopsies from immunoserologically defined patients with PF were studied by light and 
electron microscopy.
Results We found no abnormalities in N- PF skin, whereas all the N+ skin biopsies displayed in-
tercellular widening between desmosomes, a decreased number of desmosomes and hypoplastic 
desmosomes in the lower epidermal layers. Acantholysis was present in two of five N+ biopsies, 
but only in the upper epidermal layers. The lesional skin biopsies displayed acantholysis in the 
higher epidermal layers. Hypoplastic desmosomes were partially (pseudo–half–desmosomes) or 
completely torn off from the opposing cell.
Conclusions We propose the following mechanism for acantholysis in PF: initially PF IgG causes 
a depletion of non-junctional Dsg1, leading to intercellular widening between desmosomes 
starting in the lower layers and spreading upwards. Depletion of non-junctional Dsg1 impairs 
the assembly of desmosomes, resulting in hypoplastic desmosomes and a decreased number 
of desmosomes. In addition, antibodies might promote disassembly of desmosomes. In the 
upper layers of the epidermis, where Dsg3 is not expressed and cannot compensate for Dsg1 
loss, ongoing depletion of Dsg1 will finally result in a total disappearance of desmosomes and 
subsequent acantholysis.
Introduction
Pemphigus is a chronic mucocutaneous autoimmune blistering disease, characterized by blister-
ing of the skin and ⁄or the mucous membranes due to autoantibodies directed, among others, 
against the desmosomal cadherins, desmoglein (Dsg)1 and ⁄or Dsg3.1 The two main forms of 
pemphigus are pemphigus vulgaris (PV) and pemphigus foliaceus (PF). In mucosal-dominant PV, 
patients have suprabasal blistering of the mucous membranes and autoantibodies against Dsg3 
only. In patients with mucocutaneous PV there is suprabasal blistering of both skin and mucous 
membranes, in combination with autoantibodies against both Dsg1 and Dsg3. PF presents as 
superficial blistering or erosive exfoliation of the skin and the autoantibodies are directed against 
Dsg1. 
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The level and localization of blisters in pemphigus is explained by the Dsg compensation hypoth-
esis, which states that one Dsg isoform can compensate for loss of the other Dsg isoform.2 In hu-
man skin, Dsg1 is present throughout the whole epidermis and its expression increases upwards 
from the basal layer. Dsg3 is absent in the subcorneal layers and its expression decreases from 
the lower to the higher layers. In mucosa, Dsg3 is expressed in all layers, while Dsg1 is expressed 
at low levels in higher layers. This implies that, in PF, blistering will occur only in the subcorneal 
layers of the skin where Dsg3 is absent. Vice versa, in mucosal-dominant PV, blistering will occur 
suprabasally in the mucosa where Dsg1 is absent. In mucocutaneous PV, both skin and mucosa 
will blister suprabasally due to loss of both Dsg1 and Dsg3. 
By applying lateral pressure with a finger on normal–appearing pemphigus skin it is sometimes 
possible to remove the epidermal sheet. This is called a positive direct Nikolsky sign (N+), while 
skin from which no epidermal sheet can be removed is called Nikolsky negative (N-).3 We con-
sider a positive direct Nikolsky sign on normal–appearing skin to be the earliest stage of clinical 
pathology in pemphigus. 
There are several theories on the pathogenesis of acantholysis in pemphigus. The steric hin-
drance theory suggests that acantholysis is the result of direct inhibition of the adhesive function 
of desmogleins by autoantibodies, which would lead to lengthwise splitting of desmosomes.4 
Alternative theories state that the autoantibodies interfere with the assembly and/or disassembly 
of desmosomes5–9 or that acantholysis is the result of outside–in signalling.10 
In the past, a small number of electron microscopic studies on the skin of patients with PF were 
performed.11–15 Since then, the knowledge on pemphigus antibodies and their targets has greatly 
increased, as well as the concepts on the mechanism of acantholysis. Therefore, in this study 
we investigated the ultrastructural changes in the skin of patients with PF from the current 
perspective. Moreover, we investigated the early stages of the acantholytic process by studying 
normal–appearing N- and N+ PF skin.
Material and methods
Patients
Skin biopsies of six patients with PF, three men and three women, were included (Table 1). The 
age of the patients varied between 19 and 92 years. The diagnosis PF was proven by histology, 
direct and indirect immunofluorescence of skin and serum, and by enzyme–linked immunosor-
bent assay (ELISA) that demonstrated exclusively anti–Dsg1 antibodies. Two patients were 
treated with systemic glucocorticosteroids at the time of biopsy. All patients had skin lesions 
when biopsies were taken.
84 Acantholysis in pemphigus / CHAPTER 4
ELISA
Patient Sex Age Dsg1 Dsg3 DIF Biopsy for EM Location
1 f 49 160 0 Perilesional skin ICS: IgG (2+ ⁄3+), 







2 f 92 150 1 Perilesional skin ICS: IgG (3+), C3c (+) IV: N- skin Arm




4 f 19 182 8 Healthy skin ICS: IgG (3+), C3c (2+), IgA; 
perilesional skin ICS: IgG (2+ ⁄3+), C3c (+ ⁄2+); 
lesional skin ICS: IgG (3+), C3c (+)
VII: N+ skin Arm
5 m 57 110 2 Healthy skin ICS: IgG (2+);  




6 m 71 >150 0 Lesional skin ICS: IgG (2+), C3c (2+) XI: lesional 
skin
Flank
Table 1 – Patient characteristics. ELISA, enzyme–linked immunosorbent assay; Dsg, desmoglein; DIF, direct immunofluores-
cence; EM, electron microscopy; N+, Nikolsky positive; N-, Nikolsky negative; ICS, intercellular substance.
 
Biopsies
Nine biopsies were included, two from N- skin, five from N+ skin, and two from lesional skin 
(Table 1). Rubbing for the Nikolsky sign was performed juxtaposed to the biopsy site at a 
distance of 2 cm, so that the actual biopsied normal appearing skin remained undisturbed by the 
rubbing finger. We will refer to this skin as unrubbed N+ skin. Two biopsies from normal human 
skin served as reference controls.
Light and electron microscopy
The biopsy specimens were fixed in 2% glutaraldehyde in 0.1 mol L-1 phosphate buffer, post-
fixed with 1% osmium tetroxide in 0.1 mol L-1 sodium cacodylate buffer with 1.5% potassium 
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ferrocyanide and dehydrated with ethanol. Subsequently, the specimens were embedded in 
Epon (Hexion Specialty Chemicals Inc., Danbury, CT, U.S.A.), and semithin sections were cut 
for light microscopy and ultrathin sections for electron microscopy. The ultrathin sections were 
stained with uranyl acetate and lead citrate and examined with a Philips CM100 transmission 
electron microscope (Philips, Eindhoven, The Netherlands). In selected biopsies the number of 
desmosomes per µm2 and the length of a number of desmosomes was measured.
 
Results
Nikolsky–negative pemphigus foliaceus skin
We found no abnormalities by light microscopy of the semithin sections of the N- biopsies 
(Figure 1a), although there was intercellular deposition of IgG as shown by immunofluorescence 
staining of IgG in biopsies taken from the same location. The ultrastructure also appeared normal 
(Figure 2b). Intercellular widening was not present, the desmosomes were normal in size and 
number, and no retraction of the cytoskeleton was observed. 
Unrubbed Nikolsky–positive pemphigus foliaceus skin 
Light microscopy of three of the five biopsies taken from N+ skin showed no acantholysis (Figure 
1b), while two showed acantholysis at the level of the spinous layer (Figure 1c). Electron micros-
copy showed intercellular widening without acantholysis in the basal and lower spinous layers 
(Figure 2c). We found prominent interdigitation and many filopodia in the widened intercellular 
spaces between keratinocytes. In the basal and spinous layers of N+ PF skin desmosomes were 
decreased in size. Basal layer desmosomes in N+ skin were 0.14 ± 0.05 μm vs. 0.25 ± 0.09 μm in 
N- skin and 0.26 ± 0.11 μm in control skin (p = 0.004). At the spinous layer in N+ skin the des-
mosomes measured 0.20 ± 0.09 μm vs. 0.28 ± 0.09 μm in N- skin and 0.31 ± 0.14 μm in control 
skin (p = 0.013). In N+ PF skin the number of desmosomes was also decreased at the spinous 
layer. While control skin contained 0.24 desmosomes per μm2 and N- skin 0.23 desmosomes per 
μm2, N+ skin contained only 0.10 desmosomes per μm2. 
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Figure 1 – Light microscopy of stages in pemphigus foliaceus (PF) skin. Nikolsky–negative (N-) PF skin (a) shows no abnor-
malities and immunofluorescence staining (inset) shows intercellular deposition of IgG. Nikolsky–positive (N+) PF skin reveals 
subtle intercellular widening in the lower layer (b) and immunofluorescence staining (inset) shows intercellular deposition of 
IgG. (c) Some biopsies of N+ PF skin showed acantholysis at the mid stratum spinosum (asterisks). (d) Lesional PF skin with 
transepidermal intercellular widening and complete subcorneal acantholysis (asterisk). Scale bars = 200 nm.
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Figure 2 – Electron microscopy of stages in pemphigus foliaceus (PF) skin. No intercellular widening was observed in human 
control skin (a) and Nikolsky–negative (N-) PF skin (b). In unrubbed Nikolsky–positive (N+) PF skin without acantholysis (c) 
intercellular widening between desmosomes was present at the level of the basal and suprabasal layers. In lesional acantho-
lytic PF skin (d) increased intercellular widening with prominent filopodia could be seen in all the layers below the blister. 
Scale bars = 5 μm. (a–d insets) Details (arrow) of control skin (a) and N) PF skin (b) show normal–sized desmosomes. Detail 
(arrow) of N+ PF skin (c) shows small desmosomes and detail of lesional PF skin (d) shows tiny desmosomes. Scale bars = 
200 nm. Dotted line, basal membrane zone.
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In the two N+ biopsies with acantholysis a reduction in the number of desmosomes was 
evident at the sites facing the acantholytic area. Here, desmosomes were severely hypoplastic. 
We observed plaque–like structures at the cell surface of keratinocytes (Figure 3a–c). Some of 
these structures contained one cell membrane thus resembling tiny half–desmosomes or early 
immature desmosomal nucleations (Figure 3a). Rarely, we found a normal–sized half–desmo-
some (Figure 3b). We also found plaque–like structures with a double cell membrane (Figure 
3c), pseudo–half–desmosomes, which are torn–off desmosomes resulting from an intracellular 
split between the plasma membrane and plaque in the opposite cell. Retraction of the keratin 
cytoskeleton was not observed.
Lesional skin
Both lesional skin biopsies contained subcorneal blisters (Figure 1d). Prominent intercellular wid-
ening between desmosomes was seen in all layers underneath the blister (Figure 2d). Filopodia 
were prominent in the widened intercellular spaces. Keratinocytes that were almost detached 
from their neighbours (pre–acanthocytes) had plasma membranes that were stretched
to their limits (Figure 3d). The desmosomes here were still attached but started to tear off. 
Torn–off desmosomes were visible with the point of breakage at the cytoplasmic site of the 
desmosomal plaque (Figure 3e). 
In both biopsies, desmosomes were decreased in size and number in the lower layers as well as 
in the upper epidermis (Figure 2d). Acantholytic keratinocytes that had almost lost attachment 
with their neighbouring cells showed some retraction of the cytoskeleton (Figure 3d). We found 
no half desmosomes in lesional PF skin.
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Figure 3 – Sequelae of desmosomes in pemphigus foliaceus (PF) skin. Nikolsky–positive (N+) unrubbed PF skin with (a) a 
hypoplastic halfdesmosome (arrowhead), (b) a plaque density representing a half–desmosome (arrowhead) and a ruptured 
cell membrane (double arrow). (c) This ruptured cell membrane is situated opposed to pseudo–half–desmosome plaques 
(arrows). These pseudo–half–desmosomes are attached to tonofilaments topped with a second cell membrane torn off from 
the opposing cell. Asterisk, blister cavity; scale bars = 200 nm. (d) In lesional PF skin, a decreased number of desmosomes 
(arrows) in a preacanthocyte is accompanied by peripheral retraction of tonofilaments (open circle). The cytoskeleton of the 
opposing cell (open rectangle) is not (yet) retracted. Intercellular widening between desmosomes is present between intact 
desmosomes, which are stretched to their limits (arrowheads). Scale bar = 2 μm. (e, f) Details from (d): (e) nonsplit desmo-
some torn off from the cell body; (f) some desmosomes look like torn–off desmosomes, but may be tangential sections of 
filipodia (double arrow); scale bars = 200 nm.
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Discussion
The first ultrastructural sign of pathology that could be observed in PF was intercellular widening 
between desmosomes in the basal and lower spinous layers in normal–appearing unrubbed N+ 
skin. In lesional skin, this intercellular widening became more profound and could also be seen in 
the upper epidermal layers. 
Widening between basal cells was described by Wilgram et al.11 in 1964 as the earliest visible 
change in skin of patients with PF, and has later been confirmed by others. Sotto et al.16 reported 
that, in skin of patients with endemic PF, acantholysis started with the separation of nonspecific 
junctions before desmosomes became disrupted. In line with our observations in patients, the 
spreading of intercellular widening between desmosomes from the lower to the upper layers has 
also been observed in a mouse model of endemic PF. Intercellular widening in the lower layers 
was seen 1–3 h after injection of patient IgG and, after 6–12 h, widening also occurred in the 
spinous layer.17 Intercellular widening has also been described as one of the first events in the 
pathogenesis of acantholysis in mucocutaneous PV,15,18 although others have suggested that it is 
not specific for pemphigus.14 
From cell experiments with PV sera, it is known that PV IgG binds non-junctional Dsg3, lead-
ing to its endocytosis.6,8,9 Also in PF, antibodies caused depletion of non-junctional Dsg1 in 
cultured cells.19 Although it has long been assumed that little or no Dsg1 is expressed in the 
basal epidermal layer, in normal human skin we observed a complete transepidermal staining 
pattern of Dsg1 with an increasing expression upwards from the basal layer. In skin of patients 
with PF, clustering of Dsg1 clearly starts in the basal layer.20 We propose that, in PF, depletion of 
non-junctional Dsg1 is responsible for the intercellular widening between desmosomes, starting 
in the lower layers as observed in normal–appearing N+ skin and spreading towards the upper 
layers as observed in lesional skin. This explains the ‘spongiosis’ often seen in the histopathology 
of PF skin.21 Like transadhesion between junctional cadherins, there might also be transadhesion 
between non-junctional cadherins providing for zipper–like approximation of opposite keratino-
cytes.22 This transadhesion can be either homo– or heterophylic. In case of heterophylic binding, 
loss of non-junctional Dsg1 will result in intercellular widening between desmosomes in PF. 
Additionally, or alternatively, adherens junctions can be weakened by antibodies directed against 
E–cadherin which may be present in patients with PF,23 and might result in intercellular widening 
between desmosomes as well. 
As a consequence of binding of PV IgG to non-junctional Dsg3, newly synthesized Dsg3 cannot 
be incorporated into the desmosomes anymore, leaving Dsg3–depleted desmosomes.6,8,9 Based 
on the changes in Dsg1 distribution in skin of patients with PF we previously hypothesized that 
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binding of PF IgG to Dsg1 can also deplete Dsg1 from desmosomes.20 With regard to the Dsg 
compensation hypothesis2 one could hypothesize that in the upper layers of the epidermis, 
where Dsg3 is not expressed, the depletion of Dsg1 will result in smaller and eventually a total 
disappearance of desmosomes, and subsequent acantholysis. In the lower layers where Dsg3 is 
present to compensate for the loss of Dsg1, Dsg1 depletion might result in smaller desmosomes, 
but not in acantholysis. We indeed observed a decrease in size and number of desmosomes in 
the lower epidermal layers in N+ skin. The subtle abnormalities of desmosomes at the level of 
the basal cell layer in early PF were also noted in the initial study by Wilgram et al.,11 but were 
not mentioned in later studies by others.12–15 
Acantholysis may be present in the lower spinous layers of unrubbed N+ skin, and may be 
evoked by the friction of the biopsy procedure itself (‘scissor–Nikolsky’). The lower spinous 
layers are depleted of the non-junctional and junctional Dsg1 at this stage of the pathogenesis, 
and therefore are the locus minoris resistentiae. We hypothesize that the direct Nikolsky sign 
performed on normal–appearing skin has a lower split than the marginal Nikolsky on the edge of 
a lesion. 
In one of the N+ biopsies with acantholysis we observed dense plaque–like structures in the cell 
wall at the end of tonofilament bundles that might resemble the so–called halfdesmosomes ob-
served in pemphigus skin14 and in mouse models of endemic PF17 and of PV.24 Half–desmosomes 
are explained by the steric hindrance hypothesis, that states that pemphigus antibodies bind to 
the extracellular domain of Dsg and block the transadhesion between the half–desmosomes.25 
These free plaques were observed only in the cell wall facing the blister cavity. However, a 
part of the plaques was covered by a second plasma membrane from the opposing half of the 
desmosome; therefore these structures represent pseudohalf–desmosomes, as the cell membrane 
was torn off from the opposing plaque of the desmosome. These pseudo–halfdesmosomes were 
also previously described in PV.15 Torn–off desmosomes are also seen when plaque components 
such as desmoplakin are lacking because of hereditary disease, and desmosomes cannot hold 
onto the keratin filaments.26 Apparently in pemphigus, the decrease of intercellular adhesion 
between desmosomes and the reduction in size and number of desmosomes leads to such 
transcellular forces that remaining desmosomes are stretched out and finally break between 
inner plaque and keratin filaments. The weakening behind the plaque might simply be the result 
of desmosome hypoplasia, but may also be due to cell signalling events occurring after IgG 
binding to desmogleins resulting in phosphorylation of plakoglobin (PG) and compromising the 
adherence between plaque and the intermediate filaments.10 The desmosomes are not torn off 
because of collapse of the intermediate filament cytoskeleton and cell shrinkage as explained 
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by the ‘basal cell shrinkage theory’,27 as we observed tonofilament retraction to a limited extent 
after acantholysis was almost complete, and this postacantholytic shrinkage was not confined to 
the cells in the basal layer.
In conclusion, based on the results of this ultrastructural study, we propose the following model 
for acantholysis in PF: IgG causes a depletion of non-junctional Dsg1 leading to intercellular 
widening between desmosomes. This widening starts in the lower epidermal layers and spreads 
towards the upper layers. Later, the depletion of non-junctional Dsg1 impairs the assembly of 
desmosomes, which results in a decrease in size and number of desmosomes. In addition, pem-
phigus antibodies might promote disassembly of desmosomes. In the upper epidermal layers, 
where Dsg3 is absent, ongoing depletion of Dsg1 will finally result in a total disappearance of 
desmosomes, and subsequent acantholysis.
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Abstract
Background Pemphigus is an autoimmune blistering disease due to autoantibodies targeting 
desmoglein (Dsg)1 and/or Dsg3 present in mucocutaneous desmosomes. The binding of 
pathogenic autoantibodies impairs desmosome function leading to acantholysis, however the 
mechanism behind this is unclear. 
Objectives In this study we will investigate the individual influence of Dsg1 and Dsg3 auto-
antibodies on desmosome size and number in skin of patients with pemphigus foliaceus (PF), 
mucosal–dominant pemphigus vulgaris (PV), and mucocutaneous PV. 
Patients/ Methods IgG, Dsg1 and Dsg3 patterns were investigated by direct immunofluores-
cence (DIF) microscopy. The size and number of desmosomes were determined by electron 
microscopy.
Results In Nikolsky negative (N–) PF skin there was minimal clustering of Dsg1 in the basal layer, 
while in Nikolsky positive (N+) PF skin Dsg1 clustering spread up to the suprabasal layers. N+ PF 
skin had smaller and less desmosomes than N– PF skin, or control skin. In mucosal-dominant PV 
skin Dsg3 was clustered and strongly reduced, but the desmosomes remained of normal size and 
number. In skin of mucocutaneous PV patients with autoantibodies against both Dsg1 and Dsg3 
a reduction of desmosome size but not in number was found.




Pemphigus is a chronic mucocutaneous autoimmune blistering disease caused by autoantibodies 
directed against the desmosomal cadherins, desmoglein (Dsg)1 and/or Dsg3. In patients with 
pemphigus foliaceus (PF), there is superficial blistering of the skin but not of mucous mem-
branes, with autoantibodies directed against Dsg1. In mucosal–dominant pemphigus vulgaris 
(PV), mucous membranes are involved but not the skin, with autoantibodies directed against 
Dsg3. Mucocutaneous PV is characterized by suprabasal blistering of both the skin and mucous 
membranes, with autoantibodies directed against both Dsg1 and Dsg3. 
Desmosomes are intercellular adhering discoid junctions serving to attach neighboring cells to 
each other. Their diameter varies between 0.2 and 0.7 μm in the epidermis. During epidermal 
differentiation, smaller, less well–organized desmosomes in the basal cells are replaced by larger, 
more electron–dense structures in the upper layers.1–4 
Desmosomes are composed of members of at least three protein families. Desmosomal cadher-
ins (desmogleins and desmocollins) constitute the transmembrane adhesive interface, whereas 
armadillo and plakin family proteins build up the cytoplasmic plaques. The cytoplasmic tail of 
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the transmembrane desmogleins and desmocollins interacts with plakoglobin (PG), which in turn 
binds to desmoplakin. Desmoplakin anchors to the intermediate filaments. The interactions are 
stabilized laterally by plakophilin.2,5 
In pemphigus, both anti–Dsg1 and anti–Dsg3 antibodies can cause acantholysis, although the 
actual pathomechanism is unknown. Current theories include steric hindrance, desmosomal 
nonassembly and disassembly, or cell signalling. 
We recently described the ultrastructure of the epidermis in PF patients.6 We found no abnor-
malities in the desmosomes or in the intercellular distance in Nikolsky–negative (N-) PF skin, 
whereas in Nikolsky–positive (N+) PF skin we observed intercellular widening between the 
desmosomes and a slight reduction in the size and number of desmosomes in the lower epider-
mal layers but not in the higher ones. Full acantholysis was only observed in lesional PF skin due 
to a severe reduction in the size and number of desmosomes in the higher epidermal layers.6 In 
the present study, we performed morphometric studies on the skin of PF, mucosal-dominant PV, 
and mucocutaneous PV patients to determine the influence of Dsg1 and Dsg3 autoantibodies on 
the number and length of desmosomes. We correlated the morphometric data to the immuno-
fluorescence staining pattern of the most important immunological effectors in pemphigus: IgG, 
Dsg1, and Dsg3.
Materials and methods
Skin biopsies of two human controls, and eight pemphigus patients were studied. The skin bi-
opsies were taken from N- or N+ non–lesional skin from four PF patients (two N- and two N+), 
two mucosal-dominant PV patients (both N-), and two mucocutaneous PV patients (one N- and 
one N+). The diagnosis of PF, mucosal-dominant PV, or mucocutaneous PV was confirmed by 
histology, direct immunofluorescence (DIF) and indirect immunofluorescence (IIF) of the skin 
and serum, and by enzyme-linked immunosorbent assay (ELISA) that demonstrated exclusively 
anti–Dsg1 antibodies in the case of PF, anti–Dsg3 in the case of mucosal-dominant PV, and both 
Dsg1 and Dsg3 antibodies in the case of mucocutaneous PV. Two biopsies were taken from each 
patient at the same location. One biopsy was used for immunofluorescence staining and the 
other for electron microscopy. The biopsies used for immunofluorescence staining were taken 
as a part of the standard patient care. For the biopsies used for electron microscopy informed 
consent was documented in the patient files. Rubbing for the Nikolsky sign was performed jux-
taposed to the biopsy site at a distance of 2 cm, so that the biopsy site, which appeared normal, 
remained undisturbed by the rubbing.
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Results
In control skin samples, IgG was absent (Figure 1a and d) and Dsg1 and Dsg3 were distributed 
smoothly over the cell membranes (Figure 1b and e). Morphometric analysis showed that the 
average size of the desmosomes in the different layers was comparable, with 0.25 μm in the 
basal layer, 0.31 μm in the spinous layer, and 0.30μm in the granular layer (Figure 2 and Figure 
S1 a–c). The number of desmosomes increased from the basal layer upward: 0.15 per μm2 in the 
basal layer, 0.26 per μm2 in the spinous layer, and 0.48 per μm2 in the granular layer. 
 
Figure 1 – Distribution of desmoglein (Dsg)1 and Dsg3 in the skin of pemphigus patients. In normal human skin (NHS), 
mucosal–dominant pemphigus vulgaris (mdPV) skin, and Nikolsky–negative (N- mucocutaneous PV (mcPV)) skin, there is 
an even distribution of Dsg1 around the cells (b, t, z). In N- pemphigus foliaceus (PF) skin, clustering of Dsg1 starts at the 
basal layer (h). In Nikolsky–positive (N+) PF skin, clustering of Dsg1 is present at the level of the basal, spinous, and granular 
layers (n). In N+ mcPV skin, clustering of Dsg1 is present throughout the layers (a, f). Dsg3 has a smooth staining pattern in 
NHS and PF skin (e, k, q), whereas in mdPV (w) and mcPV skin (ac, ai) Dsg3 shows heavy clustering and a reduced level of 
expression. Scale bar = 40 μm.
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Figure 2 – Desmosome length in the skin of pemphigus patients. Desmosomes at the level of the basal layer and the spinous 
layer in Nikolsky–positive pemphigus foliaceus (N+ PF) and Nikolsky–positive mucocutaneous pemphigus vulgaris (N+ 
mcPV) skin are smaller than those in normal human skin (NHS). mdPV, mucosal–dominant pemphigus vulgaris; N-, Nikolsky 
negative.
 
In N- PF skin samples, we saw limited IgG deposition on the epithelial cell surface (ECS) in the 
basal layer (Figure 1g and j). There was also some limited clustering of IgG and Dsg1 in the basal 
cell layer (Figure 1g–i). The desmosomal size (Figure 2 and Figure S1 d–f) and the number of 
desmosomes per μm2 in the different layers were comparable to the control samples. 
In the N+ PF skin, there was clustered deposition of IgG and Dsg1 at the basal and spinous 
layers (Figure 1m–o). Dsg3 kept its smooth distribution as in the control samples and N- PF 
samples (Figure 1q). The desmosomes in the N+ PF skin were significantly smaller in the basal 
and spinous layers, measuring on average 0.18 μm and 0.20 μm, respectively, compared with 
those in control and N- PF skin, (Figure 2 and Figure S1 g and h). The number of desmosomes in 
the spinous layer was reduced to 0.13 per μm2. 
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Immunofluorescence staining of mucosal-dominant PV skin that was not affected showed tran-
sepidermal IgG deposition in a clustered ECS pattern (Figure 1s and v). Dsg3 followed the pat-
tern of the IgG and was also strongly reduced compared with normal skin (Figure 1w), whereas 
Dsg1 had a smooth distribution (Figure 1t). However, the size and number of desmosomes over 
the different layers were comparable to control skin samples (Figure 2 and Figure S1 j–l).
In N- mucocutaneous PV skin, IgG and Dsg3 were clustered throughout the layers of the 
epidermis (Figure 1ab–ad), whereas Dsg1 was still distributed smoothly (Figure 1z). As in muco-
sal-dominant PV skin, the desmosomal size (Figure 2 and Figure S1 m–o) and number remained 
normal. In the basal layer, the desmosomal size was reduced, but this was not statistically 
significant compared with that in normal skin samples. 
In N+ mucocutaneous PV skin, however, Dsg1 co–clustered with IgG and Dsg3 (Figure 1ae–aj). 
Now the desmosomal size was significantly reduced compared with control skin samples at both 
the basal and spinous layers, where the desmosomes measured only 0.17 μm (Figure 2 and 
Figure S1 p and q). The number of desmosomes was not changed. 
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Figure S1 – Electron microscopy of pemphigus patient skin samples. Small desmosomes are present in Nikolsky-positive (N+) 
pemphigus foliaceus (PF) and N+ mucocutaneous PV (mcPV) skin at the level of the basal and spinous layers (g, h, p and q). 
The desmosomes are normal in size at the level of the granular layer in N+ PF and N+ mcPV skin (i and r), and in all other 
biopsies. Scale bar = 200 nm.
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Disussion
Previously, we showed that in the skin of pemphigus patients, IgG binding induced clustering 
of the Dsg autoantigens and that this can be used as an in vivo marker of antigen binding.7 In 
a subsequent study, we observed that, to a limited extent, the desmosomes were smaller in the 
lower but not in the higher epidermal layers of N+ PF skin. The reduction of desmosome size 
extends to the higher layers and advances further in the higher layers of lesional PF skin, where 
spontaneous acantholysis occurred.6 
With this morphometric study, we have shown that desmosomal size is decreased in the lower 
layers of N+ PF skin and N+ mucocutaneous PV skin, but not in mucosal-dominant PV skin. In 
N+ PF and mucosal-dominant PV skin samples, there was clustering of Dsg1 and Dsg3, respec-
tively, whereas in mucocutaneous PV skin both Dsg1 and Dsg3 were clustered. Dsg clustering is 
therefore an antigen marker of IgG binding, but is not necessarily pathogenic, as Dsg3 clustering 
was also observed in clinically unaffected mucosal-dominant PV skin, in which the desmosome 
size remained normal. 
We therefore believe that the effects of Dsg1 antibodies on the epidermis are as follows: IgG 
directed against Dsg1 enters the epidermis from the dermis. First it contacts the basal layer. It 
binds to non–desmosomal Dsg1, where it assembles in large clusters, most likely by extensive 
cross–linking. As a first effect of the depletion of non-desmosomal Dsg1, intercellular widening 
occurs. Then, when the desmosomes also become depleted of Dsg1, they shrink in size and 
number. When the amount of anti–Dsg1 IgG increases, the IgG will spread further upward into 
the higher layers, also leading to intercellular widening and desmosomal reduction there. Finally, 
when the IgG reaches the layers where Dsg3 is absent and cannot compensate for the loss of 
Dsg1, desmosomes will no longer be able to form stable structures and will melt away with 
subcorneal acantholysis as the final result. 
The effects of anti–Dsg3 antibodies on the epidermis differ from those of anti–Dsg1 antibodies. 
IgG directed against Dsg3 spreads through the epidermis and leads to clustering and depletion 
of Dsg3 throughout the Dsg3–expressing layers. This does not, however, lead to intercellular 
widening or a reduction in the size and number of the desmosomes. Apparently, loss of Dsg3 
is less devastating than loss of Dsg1 to the desmosomes as they retain their normal shape. This 
fits with observations in patients with mucosal-dominant PV, who have blistering of the mucous 
membranes but a perfectly healthy and strong skin. Although their skin is loaded with anti–cell 
surface IgG deposits, it does not blister, even when it is firmly rubbed to elicit the Nikolsky sign. 
Next, when antibodies directed against Dsg1 are also present in addition to antibodies against 
Dsg3 (as in mucocutaneous PV), the depletion of Dsg1 will affect the desmosomes, which then 
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start to shrink. As the desmosomes can no longer compensate for the loss of both Dsg1 and 
Dsg3, they will melt away in the lower layers, which eventually leads to suprabasal acantholysis. 
We therefore conclude that Dsg1, but not Dgs3, is necessary for preserving the normal size and 
number of desmosomes in the human epidermis and that loss of Dsg1 is conditional for develop-
ing cutaneous acantholysis in pemphigus.
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Abstract
Background The exact mechanism by which autoantibodies against desmogleins induce acan-
tholysis in pemphigus remains unsolved. 
Objectives In this study we explore the role of apoptosis in pemphigus acantholysis.
Patients/ Methods Twenty–two skin biopsies from pemphigus vulgaris (PV) and pemphigus 
foliaceus (PF) patients and eight biopsies from a PV and PF in vitro skin model were included. 
In these biopsies immunofluorescence staining of cleaved caspase 3, cleaved caspase 8, poly 
(ADP-ribose) polymerase (PARP), fractin and TUNEL was performed. Fourteen skin biopsies from 
PV and PF patients were studied by electron microscopy for morphological features of apoptosis. 
Results In pemphigus patient skin and the in vitro skin model there was no expression of 
apoptotic markers. A few TUNEL positive cells were seen in three lesional PF biopsies and in the 
biopsies from the in vitro skin model. However, these observations did not differ from control 
biopsies. None of the PV and PF skin biopsies showed electron microscopic morphological 
features of apoptosis. 
Conclusions The absence of specific apoptotic signalling and morphological features of apop-




Pemphigus is a group of rare mucocutaneous autoimmune bullous diseases that are charac-
terized by intra–epidermal IgG deposition and loss of cohesion between keratinocytes, known 
as acantholysis. Although the pathogenic relevance of anti–desmosomal IgG has been clearly 
demonstrated, the exact mechanism by which IgG induces loss of adhesion remains unsolved. 
Cell signalling has received a lot of attention in the past years, including the death signalling 
(apoptotic) pathways. Apoptosis can be activated via an extrinsic or intrinsic pathway. In the 
extrinsic pathway, Fas L binds to the Fas receptor, which leads to the activation of caspase 8. In 
the intrinsic pathway, subsequently p53, bax, cytochrome c, and caspase 9 are activated. Both 
caspases 8 and 9 activate the common pathway caspase 3. Caspase 3 induces DNA fragmenta-
tion, which can be detected with poly (ADP–ribose) polymerase (PARP), fractin, and TUNEL.1,2 
Apoptosis has been suggested as an upstream event in acantholysis, but alternatively, also as 
a downstream event after loss of cell–cell adhesion.3–5 4 Furthermore, it has been hypothesized 
that IgG might induce apoptotic enzymes but that these do not lead to cell death but instead to 
acantholysis, a mechanism referred to as apoptolysis.6 
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A thorough examination of the literature on apoptosis in pemphigus revealed that the possible 
involvement of apoptosis in acantholysis was mainly studied in cultured cell and/or mouse 
models, but rarely in patient skin.3 Despite this, the caspase pathway has already been suggested 
as a therapeutic target in pemphigus.7 This, together with, as mentioned before, conflicting 
results from various studies, propelled us to reinvestigate this topic. We therefore searched 
for evidence of apoptosis in pemphigus patient skin and in an in vitro skin model, wherein we 
induced acantholysis by patient IgG. We checked for activation of both the intrinsic and the 
extrinsic pathway by immunofluorescence and, furthermore, used electron microscopy to look 
for hallmarks of apoptosis.
Materials and methods
Pemphigus patient skin for immunofluorescence
For immunofluorescence, we included 11 biopsies from 9 mucocutaneous pemphigus vulgaris 
(PV) patients (5 from healthy skin, 3 from perilesional skin, and 3 from lesional skin), and 11 
biopsies from 7 pemphigus foliaceus (PF) patients (4 from healthy skin, 2 from perilesional 
skin, and 5 from lesional skin). Pemphigus biopsies were selected from patients with increased 
anti–Dsg antibodies determined by enzyme–linked immunosorbent assay (ELISA) (increased 
anti–Dsg1 and anti–Dsg3 index for mucocutaneous PV, increased anti–Dsg1 and normal Dsg3 
index for PF). Moreover, all pemphigus biopsies needed to show pemphigus specific epithelial 
cell surface (ECS) IgG depositions. All samples were immediately frozen in liquid nitrogen and 
stored at –80°C. All used patient tissue was residual tissue, taken in the past for diagnostics. For 
this reason patient consent for experiments was not required. Immunofluorescent analysis was 
performed for cleaved caspase 3, cleaved caspase 8, cleaved PARP, fractin, and TUNEL. For all 
the stainings except TUNEL, one healthy skin sample was used as negative control9 and one 
basal cell carcinoma tissue sample, one colon carcinoma tissue sample and one toxic epidermal 
necrolysis (TEN) skin sample served as positive controls.10–12 For TUNEL four normal human skin 
samples served as negative controls and four samples of the same skin treated for 10 minutes 
with DNAse 1 and one TEN skin sample served as positive controls. The control samples were 
evaluated in the same experiment as the pemphigus specimens.
Pemphigus in vitro model for immunofluorescence
We used eight biopsies from a previously described pemphigus in vitro model experiment.8 
In these experiments, healthy breast reduction skin biopsies had been incubated with purified 
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pemphigus IgG (for 4, 16, and 24 hours with PV IgG and for 24, 48, and 72 hours with PF 
IgG). The PV IgG dose was 12.2 mg/ml, the PF IgG dose was 10.8 mg/ml. After harvesting, the 
biopsies were frozen in liquid nitrogen and stored at –80°C. Again, the aforementioned controls 
(pemphigus patient skin for immunofluorescence) were evaluated in the same experiment as 
the in vitro model samples. Additionally, control incubations included three healthy IgG and two 
omission of IgG. 
Staining procedure 
The following antibodies were used to detect apoptosis: cleaved caspase–3 rabbit monoclonal 
antibody (Cell Signalling, Danvers, U.S.A) in a dilution of 1/50, cleaved caspase–8 rabbit 
monoclonal antibody (Cell Signalling, Danvers, U.S.A) in a dilution of 1/200, cleaved PARP 
rabbit monoclonal antibody (Cell signalling, 1 Danvers, U.S.A.) in a dilution of 1/200 and fractin 
rabbit polyclonal antibody in a dilution of 1/200 (Mybiosource, San Diego, U.S.A). Cryosections 
of 4 μm were incubated overnight with one of the selected antibodies in phosphate buffered 
saline containing 1% ovalbumine (PBS–OVA) at 4°C. Next, the sections were incubated with 
donkey anti rabbit fluorescein isothiocyanate (FITC) (dilution 1/100 in PBS–OVA) labeled sec-
ondary antibody for 1 hour at room temperature. Finally, the sections were counterstained with 
bisbenzimide (BB) (1:10000 diluted in PBS) for 5 minutes at room temperature and coverslipped 
under SlowFade® Antifade reagent (Invitrogen, Paisley, U.K.). TUNEL (Roche, Mannheim, 
Germany) was performed as follows. After fixation with paraformaldehyde (4% in PBS, pH 7.4) 
for 30 minutes, the sections were permeabilized with 0.1% Triton X–100 in 0.1% sodium citrate 
for 2 min on ice. Then, the sections were incubated with the TUNEL reaction mixture containing 
terminal deoxynucleotidyl transferase (TdT) and fluorescein dUTP (diluted 1:10 in label solution) 
in a humidified chamber for 60 minutes at 37ºC in dark (sections covered with cover slip during 
incubation). After that, the sections were counterstained with BB (1:10000 diluted in PBS) for 5 
minutes at room temperature and coverslipped under SlowFade® Antifade reagent.
Evaluation of the samples
Per sample 5 high power fields were evaluated. If staining was present, between 45 and 259 
keratinocytes were evaluated in the most representative high power fields, and the percentage 
of TUNEL was counted by two independent observers.
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Pemphigus patient skin for electron microscopy
Finally, six skin biopsies (two lesional, one perilesional, and three non–lesional) from four 
mucocutaneous PV patients and nine skin biopsies (five lesional, one perilesional, and three non–
lesional) from eight PF patients were investigated by electron microscopy for ultrastructural signs 
of apoptosis. Electron microscopy was performed as described before.8 For electron microscopy, 
pemphigus patient skin biopsies were selected that met the same inclusion criteria as described 
under ‘pemphigus patient skin for immunofluorescence’. The number of sections and cells 
examined differed per sample. PV lesional 1: 7 sections (1–10 cells), PV lesional 2: 5 sections 
(2–40 cells), PV perilesional 1: 5 sections (2–15 cells), PV non-lesional 1: 4 sections (1–8 cells), 
PV non-lesional 2: 4 sections (2–25 cells), PV non-lesional 3: 5 sections (3–15 cells), PF lesional 
1: 4 sections (3–10 cells), PF lesional 2: 4 sections (2–22 cells), PF lesional 3: 4 sections (2–9 
cells), PF lesional 4: 3 sections (2–22 cells), PF lesional 5: 3 sections (2–8 cells), PF perilesional 1: 
1 section (8 cells), PF non-lesional 1: 4 sections (2–5 cells), PF non-lesional 2: 3 sections (2–10 
cells), PF non-lesional 3: 5 sections (2–20 cells). Basal cell carcinoma served as a positive control 
(Figure S3).
Figure S3 – Electron microscopy of basal cell carcinoma (BCC). Basal cell carcinoma tissue shows nuclear fragmentatie. * = 
nuclear fragmentation. Scale bar = 5 μm.
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Results
The apoptotic markers stained positive in the positive–control tissues but were absent in the 
negative controls (Figure S1). None of the pemphigus skin biopsies showed positive staining 
of cleaved caspase 3, cleaved caspase 8, fractin, or nuclear PARP. In PV, TUNEL was positive in 
0.46% (range, 0–0.97%) of lesional epidermis and in 1.25% (range, 0–2.94%) of perilesional 
epidermis. In PF, these numbers were 4.42% (range, 0–17.78%) for lesional epidermis and 
0.84% (range, 0–1.91%) for perilesional epidermis (Figure 1). In healthy pemphigus skin, posi-
tive cells were only sporadically present. In healthy control skin, 1.11% of the cells were TUNEL 
positive (range, 0–4.44%).
Acantholysis was present in PV IgG–incubated biopsies after 16 hours and in the PF IgG–incu-
bated biopsies after 48 hours. None of the in vitro model biopsies showed positive staining for 
cleaved caspase 3, cleaved caspase 8, fractin, or nuclear PARP. An intercellular PARP staining 
was present in the in vitro model biopsies. This intercellular staining pattern was also present in 
healthy skin and in the additional controls of the in vitro model. Some TUNEL positive cells were 
found in the stratum granulosum of all biopsies but were absent in the layers beneath, including 
in the acantholytic biopsies. The percentages of TUNEL–positive cells found in the PV model 
were as follows: 7.46% at t=0 (non–incubated skin), 0% at t=4, 4.03% at t=16, and 3.17% at 
t=24. For the PF model, these percentages were 1.26% at t=0, 2.32% at t=24, 3.46% at t=48, 
and 1.62% at t=72 (Figure S2).
All perilesional and lesional biopsies showed widening of intercellular spaces by electron micros-
copy. The lesional biopsies showed a decreased number of desmosomes. None of the biopsies, 
however, showed any morphological features of apoptosis, i.e., rounding up of the cell, retrac-
tion of pseudopods, pyknosis, karyorrhexis, plasma membrane blebbing, and engulfment by 
resident phagocytes (Figure 2).
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Figure S1 – (a) Immunofluorescence of controls (cl caspase 3, cl caspase 8, PARP, fractin) In the HE staining colon carcinoma 
tissue, basal cell carcinoma tissue and toxic epidermal necrolysis (TEN) tissue show apoptotic hallmarks while healthy skin 
shows no abnormalities. Colon carcinoma tissue, basal cell carcinoma tissue, and TEN tissue show cytoplasmic staining of cl 
caspase 3 and cl caspase 8. PARP shows nuclear staining in basal cell carcinoma tissue, colon carcinoma and TEN tissue and 
an intercellular staining pattern in the healthy skin. Besides cytoplasmic staining fractin shows staining of apoptotic bodies 
in the positive controls. Healthy skin shows negative staining for cl caspase 3, cl caspase 8 and fractin. Scale bar = 20 μm 
(only for Immunofluorescence) (b) Immunofluorescence of controls (TUNEL) TUNEL was extensively expressed in DNAse 1 
treated skin and TEN tissue while it was only focally present in label treated healthy control skin. Scale bar = 20 μm
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Figure 1 – Immunofluorescence of lesional pemphigus patient skin. Hematoxylin and eosin (H&E) staining shows pemphi-
gus vulgaris (PV) skin with blistering in the suprabasal layer and pemphigus foliaceus (PF) skin with acantholysis within the 
granular layer. PV lesional (1–2) skin shows absence of staining of cl caspase 3, cl caspase 8, poly (ADP–ribose) polymerase 
(PARP), and fractin. PF lesional skin (1–5) shows absence of staining of cl caspase 3, cl caspase 8, and fractin. PARP shows 
staining with an intercellular pattern in PF lesions 4–5, whereas it is absent in PV lesions 1–3. PV lesion 2, PF lesions 2, 4–5 
show absence of TUNEL, whereas PV lesion 1 and PF lesions 1,3 show a few TUNEL–positive cells. Bar = 50 μm.
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Figure S2 – Immunofluorescence of pemphigus–IgG treated redundant breast reduction skin. HE staining shows no ab-
normalities after zero and 4 hours of pemphigus vulgaris (PV)–IgG incubation and after zero and 24 hours of pemphigus 
foliaceus (PF)–IgG incubation. After 16 and 24 hours of PV–IgG incubation acantholysis is seen within the suprabasal layer. 
After 48 hours of PF–IgG incubation acantholysis is seen in the subcorneal layer. In the PF model PARP is present with an 
intercellular pattern at all time points while all the other apoptotic markers are absent. A few TUNEL positive cells are seen in 
all biopsies except for PV T4. Scale bar = 20 μm 
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Figure 2 – Electron microscopy of lesional pemphigus skin. Pemphigus vulgaris (PV) lesional skin (1, 2) and pemphigus folia-
ceus (PF) lesional skin (1–4) show acantholysis in absence of apoptotic features (rounding up of the cell, retraction of pseu-
dopods, pyknosis, karyorrhexis, plasma membrane blebbing, and engulfment by resident phagocytes). In all of the lesional 
biopsies, a widening of the intercellular spaces and a decreased number of desmosomes were seen. *Blister. Bar = 5 μm. 
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Discussion
In conclusion, we found no evidence of apoptotic cells in pemphigus acantholysis. First, apop-
totic signalling of both the intrinsic and the extrinsic pathway was absent in 22 skin biopsies of 
pemphigus patients and in the in vitro model at any time point. Second, although some TUNEL 
staining was seen in two acantholytic PF biopsies and one PV biopsy, and in the pemphigus 
model, we also found TUNEL–positive cells in normal healthy skin, especially in the granular 
layers. The expression of TUNEL in the pemphigus skin and model was also seen in the stratum 
granulosum, above the blisters. If apoptosis would be a cause of acantholysis, then TUNEL posi-
tivity should have been present below the blister cavity. Third, ultrastructurally no morphological 
features of apoptosis were present. It should be noted that electron microscopy is considered to 
be the gold standard for the identification of apoptotic cells.13 
Our results are in line with the findings of Schmidt et al. who conclude that apoptosis is not re-
quired for pemphigus acantholysis.4 Like us, they found no evidence of positive cleaved caspase 
3 and TUNEL when analyzing lesional PV patient skin. Moreover, in cultures of human keratino-
cytes treated with PV IgG, they also found acantholysis in absence of positive TUNEL staining 
as well as caspase 3 cleavage. Lee et al. also disagreed that apoptosis is an upstream event in 
pemphigus acantholysis.5 In PF IgG–treated mice and PV IgG–treated keratinocyte cultures, they 
found activation of cleaved PARP, cleaved caspase 3, and TUNEL, but only after acantholysis. 
The belief that apoptosis is an upstream event in acantholysis is largely based on studies in 
model systems.3 We question whether these model systems are suitable for answering such 
questions on pemphigus pathogenesis, as they differ from the in vivo situation. For instance, 
in cultured keratinocytes the desmosomal makeup in terms of molecular composition does not 
accurately reflect the in vivo situation.14 As for mouse models, the repertoire of expressed genes 
involved in apoptosis in humans and mice is different.15 Furthermore, previous data on pemphi-
gus skin are scarce and based on a few lesional biopsies only.16–18 
In conclusion, this study does not support the hypothesis that apoptosis is involved in pemphigus 
acantholysis. However, although we studied morphological hallmarks of apoptosis, the involve-
ment of certain apoptotic caspases or signalling pathways, which might be involved in dissocia-
tion of (inter)desmosomal adhesion complexes, cannot be excluded.6
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The aim of this thesis was to gain more insight in acantholysis in pemphigus by studying pem-
phigus skin using histology, immunohistochemistry and electron microscopy. Most investigators 
have used in vitro cell models and mouse models to study the pathogenesis of pemphigus. In 
this thesis we will focus on actual patient skin biopsies and organ cultures of human skin. 
In the Center for Blistering Diseases at the University Medical Center Groningen we see about 
10 new patients per year with pemphigus vulgaris (PV) and pemphigus foliaceus (PF) referred 
to us from all over the Netherlands. Therefore we have been able to collect a number of well 
documented patient biopsies and serum samples. We have the unique opportunity to conduct 
translational medical science by using clinical material for basic science. Using both PF and PV 
biopsies and samples enabled us to study the effects of both desmoglein (Dsg)1- and Dsg3 
autoantibodies on human skin cells. 
In chapter 2 we give an overview of the human models that have been used in the past to study 
the pathogenesis of pemphigus, i.e. organ cultures of human skin, cultured human monolayer 
keratinocytes, reconstituted skin and human skin grafted on mice. 
The organ cultures of human skin that we used are based on the organ culture systems of 
Michel and Ko.1 In this model human skin biopsies were either placed on a transwell such that 
the bottom of the biopsy contacts the solution containing patient IgG or they were submerged 
in a solution containing IgG. The latter approach enables to incubate several biopsies in one and 
the same volume of medium with added pemphigus IgG or Fab fragments. The biopsies can 
be harvested at any time and processed for light microscopy, immunofluorescence or electron 
microscopy. Submerged culturing induces shifts in the expression of the different cadherins, but 
this manifests only after culturing longer than 24 hours. The major advantage of our explant 
model is that it is actual human skin with the correct architecture and desmosomal make–up of 
all epidermal layers. The level of blistering induced by pemphigus IgG is comparable to that in 
patient skin i.e. suprabasal splits are induced by PV IgG and subcorneal acantholysis is induced 
by PF IgG. 
The majority of the past studies have been conducted with in vitro monolayers of cultured cells. 
In chapter 2 we also described the expression of desmosomal components by the various used 
monolayers. When cultured in high calcium, monolayers of normal human epidermal keratino-
cytes (NHEKs) express Dsg3 and after several days, the differentiating cells also start expressing 
Dsg1. Furthermore, they also express Dsg2 and as such differ from the cells of the basal layer 
of the native epidermis. Since acantholysis is only present in cells that either express Dsg3 alone 
(basal layer of oral mucosa) or Dsg1 alone (granular layer of epidermis), cultured cells therefore 
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do not represent an ideal model system to study PF and mucosal-dominant PV acantholysis. To 
answer future questions concerning the pathogenesis of pemphigus, one should use patient skin, 
human models and mouse models in a complementary fashion. It is important to realize that 
the results might not be representative for the in vivo situation, and that data derived from for 
example cell culture studies cannot be extrapolated to skin. 
In chapter 3 we describe the distribution of IgG and the desmosomal proteins in pemphigus 
patient skin. In PF skin, clustering of IgG, Dsg1 and plakoglobin (PG) was observed. The aggre-
gation process starts low in the basal layer and when more IgG becomes available aggregation 
also spreads to the layers above. In skin of mucosal-dominant PV patients, Dsg3 was clustered 
and the overall Dsg3 fluorescence intensity was reduced compared to normal human skin. IgG 
and also some PG colocalized with the clustered Dsg3. Clusters composed of IgG, Dsg1 and 
PG and of IgG, Dsg3 and PG were present in the skin of patients with mucocutaneous PV. By 
using a human in vitro organ culture model in which blistering was induced by pemphigus Fab 
fragments, we demonstrated that clustering is caused by crosslinking of Dsg by bivalent IgG. 
The clusters reveal that the targeted non–junctional Dsg becomes sequestered from desmosomal 
components. 
The degree of Dsg1 clustering is correlated with the degree of intercellular widening. Light 
microscopy showed that in PF skin with profound Dsg1 clustering, keratinocytes exhibited subtle 
intercellular widening, especially between the basal cells and to a lesser degree also between 
the suprabasal cells. In lesional skin, widening also extended to higher layers. Biopsies with little 
IgG deposition and minimal Dsg1 clustering had no visible widening. By electron microscopy it 
was shown that intercellular widening was present in the basal cell layer of a Nikolsky–positive 
(N+) PF skin biopsy. Light- and electron microscopy of clinically unaffected mucosal-dominant 
PV skin showed no intercellular widening and the desmosomes were normal of size and number. 
Intercellular widening was also present in the non–lesional skin of patients with mucocutaneous 
PV which showed substantial Dsg1/PG aggregation.
Based on the data of chapter 3 we formulated the following nonassembly depletion hypothesis 
for acantholysis in pemphigus skin. This model follows the rule of the desmoglein compensation 
hypothesis that states that desmosomes need minimal one desmoglein, either Dsg1 or Dsg3, to 
remain functional. In pemphigus, IgG first depletes the non–junctional desmoglein. The depleted 
non–junctional desmoglein cannot be incorporated anymore into newly forming desmosomes 
and therefore the desmosomes will be depleted of the targeted desmoglein. As the IgG diffuses 
upwards from the dermis into the lower layers of the epidermis and further towards the upper 
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layers of the epidermis the effect is first visible in the lower layers, also in PF skin. However, as 
the targeted desmoglein in PF is Dsg1, there is no acantholysis in the lower layers as enough 
Dsg3 is present here to compensate for the loss of Dsg1. When the IgG spreads further up-
wards, depletion of Dsg1 will lead to melting away of desmosomes and acantholysis in the upper 
layers, where no Dsg3 is present to compensate for the loss of Dsg1. When there are antibodies 
present directed against Dsg3 only, there is no acantholysis as all layers contain sufficient Dsg1 
to completely compensate for the loss of Dsg3. In patients with antibodies against both Dsg1 
and Dsg3 the lower layers become depleted of both desmogleins and therefore acantholysis in 
mucocutaneous PV is suprabasal. 
When using Fab fragments to induce acantholysis in the in vitro model, we showed that these 
do not induce clustering of the targeted desmoglein. Therefore, it is likely to think that Fab 
fragments induce acantholysis by another mechanism than IgG. That pemphigus antibodies can 
have a different effect on desmosomes has been described by Saito et al., who showed that 
polyclonal antibodies induce clustering and smaller desmosomes in cultured keratinocytes, while 
in cells incubated with monoclonal antibodies there was no clustering and the desmosomes 
remained normal sized.2 However, it is also possible that that Fab fragments induce acantholysis 
trough nonassembly depletion. To confirm this it is necessary to study organ cultures incubated 
with Fab fragments by electron microscopy to see whether there is also interdesmosomal 
widening, smaller desmosomes and finally melting away of desmosomes. 
We furthermore observed that in PF and in mucocutaneous PV, but not in mucosal-dominant 
PV, subtle intercellular widening between the cells was present that seemed to correlate with the 
presence of clustered Dsg1.
To investigate this observation at the ultrastructural level we performed electron microscopy of 
PF patient skin biopsies in chapter 4. Most electron microscopy studies of pemphigus patient 
skin date back to the 1960s and 70s.3–7 Findings might have been overlooked or misinterpreted 
due to lack of today’s knowledge on antigen specificity and desmosome remodelling. 
We studied Nikolsky negative (N-), N+ and lesional PF patient skin. N– PF biopsies showed no 
intercellular widening, whereas N+ PF biopsies showed intercellular widening at the level of the 
basal and lower spinous layers. Also lesional PF skin showed intercellular widening between the 
desmosomes in all layers under the blister. We hypothesized that this widening is the result of 
depletion of non–junctional desmoglein. Like transadhesion between junctional Dsg, we suggest 
that is it likely that transadhesion also exists between non–junctional Dsg. Immuno–electron 
microscopy studies have already indicated that non–junctional Dsg3 exists,8 however for Dsg1 
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this has not been investigated. Depletion of Dsg3 does not seem to result in interdesmosomal 
widening, what suggests that Dsg1 and Dsg3 may have different functions in transadhesion. 
Further immuno–electron microscopic studies will be needed to demonstrate which proteins 
provide adherence at the interdesmosomal plasma membrane. 
In acantholytic N+ and lesional PF skin we observed five types of desmosomes: 1) Hypoplastic 
desmosomes, which are the result of nonassembly depletion. 2) Normal sized half desmosomes 
were sporadically seen. Half–desmosomes have been described before in PF and PV skin9 and 
might be the result of steric hindrance. However, they have also been observed in cultured 
cells and are assumed to be an intermediate in the assembly process of desmosomes.10 We 
therefore cannot exclude here that half–desmosomes in patient skin in fact represent an attempt 
of keratinocytes to restore intercellular adhesion. 3) These intermediate desmosomes might be 
represented by the hypoplastic half desmosomes which we observed frequently. 4) Torn off 
desmosomes, with the point of breakage at the cytoplasmic site of the desmosomal plaque. 5) 
Pseudohalf–desmosomes, which are plaque like structures representing torn–off desmosomes 
resulting from an intracellular split between the plasma membrane and the plaque of the 
opposing cell. 
In N– PF skin the desmosomes were normal in number. N+ PF skin showed less desmosomes at 
the level of the spinous layer. Acantholytic N+ and lesional PF skin also showed less desmosomes 
in the acantholytic area.
 
To confirm and quantify the differences in desmosome size and -number in pemphigus skin, we 
performed a morphometric electron microscopy study on PF, mucosal-dominant PV and muco-
cutaneous PV skin in chapter 5. Desmosomes in the lower layers of N+ PF and N+ mucocutane-
ous PV skin indeed appeared to be smaller in size than those in normal control skin. 
Interestingly, what our study also showed is that desmosomes in mucosal-dominant PV skin are 
not changed, neither in size nor in number. Thus, depletion of Dsg3 also does not seem to affect 
desmosomes in contrast to depletion of Dsg1. The challenge for the coming years will be to 
understand why depletion of Dsg1 affects desmosomes in such a different way than depletion 
of Dsg3. To answer this question it is necessary to know what the exact molecular composition 
of desmosomes is and what the function of each molecule is. How much of each cadherin is 
present in the desmosomes in the different layers of the epidermis? At present little is known 
about this. Maybe desmosomes contain much more Dsg1 than Dsg3. That would explain why 
depletion of Dsg3 in mucosal-dominant PV skin has no influence on desmosome size. Another 
possibility is that Dsg1 is doing extremely well in compensating for the loss of Dsg3. Immuno–
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electron microscopy studies and real time studies are needed to gain further insight into the 
mechanism of compensation by Dsg1. What also should be investigated is the possible role of 
plakoglobin (PG) in the desmosomal depletion process. In mucosal-dominant PV skin Dsg3 is 
clustered but only a very limited amount of PG is found in these clusters. In PF skin however, PG 
intensely co–clusters with Dsg1. It might be that depletion of PG accounts for the shrinkage of 
the desmosomes. Smaller desmosomes have also been described in lethal congenital epidermol-
ysis bullosa due to a homozygous nonsense mutation in the junction plakoglobin gene (JUP).11 
Immuno–electron microscopy has to show if the PG content of the desmosomes in PF is indeed 
changed.
Whether apoptosis plays a role in the pathogenesis of pemphigus is a constantly recurring 
question. Research had mainly been conducted in cell models. In chapter 6 we therefore looked 
for evidence of apoptosis in patient skin. We studied different types of pemphigus patient skin 
by immunofluorescence for activation of markers of both the intrinsic and extrinsic pathways 
of apoptosis. We used TUNEL staining and also performed electron microscopy for signs of 
apoptosis but could not find any evidence. Therefore we conclude that apoptosis is not involved 
in acantholysis in pemphigus. We consider this as an important observation as the possible 
involvement of apoptosis or part of the apoptic pathways in the mechanism of acantholysis was 
an ongoing part of the discussion until now. The absence of apoptosis in pemphigus strengthens 
other explanations for acantholysis, such as our nonassembly depletion hypothesis.
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Summary
Pemphigus is a group of chronic mucocutaneous blistering diseases caused by autoantibodies 
directed against the desmosomal cadherins desmoglein (Dsg)1 and/or Dsg3. Pemphigus is 
characterized macroscopically by blisters and erosions of the skin and/or the mucous membranes 
and microscopically by acantholysis.
Pemphigus can be divided into two major forms: pemphigus foliaceus (PF) and pemphigus 
vulgaris (PV). In patients with PF there is superficial blistering of the skin but not of mucous 
membranes, with autoantibodies directed against Dsg1 only. In mucosal-dominant PV, the 
mucous membranes are involved but not the skin, with autoantibodies directed against Dsg3. 
Mucocutaneous PV is characterized by suprabasal blistering of both the skin and mucous 
membranes, with autoantibodies directed against both Dsg1 and Dsg3. The localization (skin 
and/or mucous membranes) and level of blistering in pemphigus patients can be explained by 
the desmoglein compensation theory. This theory states that co-expression of Dsg1 and Dsg3 
protects against acantholysis due to antibody-induced dysfunction of Dsg1 or Dsg3 alone. 
The exact mechanism by which pemphigus IgG induces acantholysis has been subject of debate. 
Acantholysis has been explained by several theories: 1) steric hindrance: this theory is based on 
the idea that there is direct interference of pemphigus IgG with the amino-terminal extracellular 
domain of desmogleins which form the trans-adhesive interface between keratinocytes. 2) cell 
signalling: signalling pathways involving p38MAPK, RhoA, PKC, plakoglobin and c-myc have 
been shown to play a role in the pathogenesis of pemphigus. Also the pathways leading to 
apoptosis have been implicated to play a role in the pathogenesis of pemphigus. 3) impairment 
of desmosome assembly and increased desmosome disassembly: binding of PV IgG to non-junc-
tional desmoglein results in prevention of desmosome assembly. It is also possible that PV IgG 
binds to desmoglein integrated in the core domain of desmosomes which leads to exclusion of 
the bound desmoglein from the desmosome and increased desmosome disassembly. 
In this thesis we will gain more insight into the pathogenesis of pemphigus by studying acan-
tholysis in pemphigus patient skin and in an organ culture model of human skin by using light-, 
immunofluorescence- and electron microscopy. 
In chapter 2 we describe the human cell and tissue models of pemphigus, i.e. organ cultures of 
human skin, keratinocyte cultures and human skin grafted on mice. The human organ culture 
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model closely mimics the architecture of the epidermis and layer specific changes in morphology 
or protein localization can easily be studied by light-, immunofluorescence- or electron micros-
copy. However, the organ cultures are less suitable to answer biochemical questions concerning 
molecular pathways. Cultured keratinocytes monolayers are convenient in this respect, but 
their desmosomal make-up in terms of adhesion molecules does not exactly reflect the in vivo 
situation. In models of human skin grafted on mice, acantholysis can be studied in actual human 
skin but now with all the advantages of an animal model.
In chapter 3 we analysed the distribution of IgG and desmosomal adhesion molecules in skin 
biopsies of 18 patients with PV and 10 with PF by double staining immunofluorescence. In PF 
skin Dsg1, but not Dsg3, was aberrantly distributed in the same partly granular pattern as the 
IgG. Vice versa, in skin of PV patients with anti-Dsg3 antibodies, Dsg3, but not Dsg1 colocalized 
with the granular IgG. Plakoglobin also coclustered with IgG and desmoglein, but this was far 
more prominent with Dsg1 than with Dsg3. In areas of heavy Dsg1 clustering, but not in areas 
of heavy Dsg3 clustering, intercellular widening between keratinocytes was present. The effect 
of IgG on desmosomal proteins was studied in an in vitro model. Patient IgG, but not Fab 
fragments, induced the same desmoglein clustering in vitro. From these results we concluded 
that IgG-induced clustering of the desmoglein auto antigens underlies the granular IgG deposi-
tion in patient skin. In PF and in mucocutaneous PV, Dsg1 clustering, but not Dsg3 clustering, 
correlates with non-acantholytic intercellular widening between desmosomes. In the patient the 
desmoglein becomes sequestered from desmosomal components, which fits with the desmoglein 
nonassembly depletion hypothesis, indicating that targeted non-junctional desmoglein is no 
longer available to be incorporated into desmosomes and this leads to disturbed assembly, and 
desmoglein-depleted desmosomes.
To further investigate the intercellular widening between desmosomes in PF, we studied two 
Nikolsky negative (N-), five Nikolsky positive (N+) and two lesional PF skin biopsies by light- and 
electron microscopy in chapter 4. We found no abnormalities in N- PF skin, whereas all the 
N+ skin biopsies displayed intercellular widening between desmosomes, a decreased number 
of desmosomes and hypoplastic desmosomes in the lower epidermal layers. Acantholysis was 
present in two of five N+ biopsies, but only in the upper epidermal layers. The lesional skin 
biopsies displayed acantholysis in the higher epidermal layers. Hypoplastic desmosomes were 
partially (pseudo-half desmosomes) or completely torn off from the opposing cell. Based on 
these results we concluded that PF IgG causes a depletion of non-junctional Dsg1, leading to 
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intercellular widening between desmosomes starting in the lower layers and spreading upwards. 
Depletion of non-junctional Dsg1 impairs the assembly of desmosomes. In addition, antibodies 
might promote disassembly of desmosomes. In the upper layers of the epidermis, where Dsg3 
is not expressed and cannot compensate for Dsg1 loss, ongoing depletion of Dsg1 will finally 
result in a total disappearance of desmosomes and subsequent acantholysis. 
To confirm and quantify the differences in size and number in pemphigus skin, we performed 
a morphometric electron microscopy study in chapter 5. We studied the individual influence of 
Dsg1 and Dsg3 autoantibodies on desmosome size and number in skin of patients with PF, mu-
cosal-dominant PV and mucocutaneous PV. IgG, Dsg1 and Dsg3 patterns were investigated by 
direct immunofluorescence microscopy. The size and number of desmosomes were determined 
by electron microscopy. In N- skin there was minimal clustering of Dsg1 in the basal layer while 
in N+ PF skin Dsg1 clustering spread up to the suprabasal layers. N+ PF skin had smaller and less 
desmosomes than N- PF skin, or control skin. In mucosal-dominant PV skin Dsg3 was clustered 
and strongly reduced, but the desmosomes remained normal of size and number. In skin of 
mucocutaneous PV patients a reduction of desmosome size but not in number was found. These 
results lead to the conclusion that Dsg1, but not Dsg3, is necessary for preserving the normal 
size and number of desmosomes in human epidermis and that loss of Dsg1 is conditional for 
developing cutaneous acantholysis in pemphigus. 
Whether apoptosis plays a role in the pathogenesis of pemphigus is a constantly recurring ques-
tion. In chapter 6 we therefore studied biopsies from PV and PF patients and biopsies from a PV 
and PF in vitro model by immunofluorescence staining of cleaved caspase 3, cleaved caspase 8, 
poly-(ADP-ribose) polymerase (PARP), fractin and TUNEL. Also biopsies from PV and PF patients 
were studied by electron microscopy for morphological features of apoptosis. In pemphigus 
patient skin and the in vitro skin model there was no expression of apoptotic markers. A few 
TUNEL positive cells were seen in lesional PF biopsies and in the biopsies from the in vitro skin 
model. However, these observations did not differ from control biopsies. None of the PV and PF 
skin biopsies studied by electron microscopy showed morphological features of apoptosis. These 
results do not support the hypothesis that apoptosis is involved in pemphigus acantholysis.
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Samenvatting
Pemphigus is een groep chronische mucocutane blaarziekten die veroorzaakt wordt door autoan-
tilichamen gericht tegen de desmosomale cadherines desmogleïne (Dsg)1 en/of Dsg3. Pemphigus 
wordt macroscopisch gekenmerkt door blaren en erosies van de huid en/of de slijmvliezen en 
microscopisch door acantholyse.
Pemphigus kan onderverdeeld worden in twee hoofdvormen: pemphigus foliaceus (PF) en 
pemphigus vulgaris (PV). Patiënten met PF hebben oppervlakkige blaarvorming van de huid, 
maar niet van de slijmvliezen en de autoantilichamen zijn alleen gericht tegen Dsg1. Mucocutane 
PV wordt gekenmerkt door suprabasale blaarvorming van zowel de huid als de slijmvliezen en de 
autoantilichamen zijn gericht tegen zowel Dsg1 als Dsg3. Patiënten met PV oris hebben slijm- 
vliesafwijkingen maar de huid is niet aangedaan en de autoantilichamen zijn gericht tegen 
Dsg3. De lokalisatie (huid en/of slijmvliezen) en het niveau van de blaren bij pemphigus kunnen 
verklaard worden door de desmogleïne compensatie theorie. Deze theorie gaat ervan uit dat 
co-expressie van Dsg1 en Dsg3 beschermt tegen acantholyse veroorzaakt door antilichaamgeïn-
duceerde dysfunctie van Dsg1 of Dsg3 alleen.
Het exacte mechanisme waardoor pemphigus IgG acantholyse veroorzaakt is onderwerp van 
discussie geweest. Acantholyse kan verklaard worden door verschillende theorieën: 1) steri-
sche hindering: deze theorie is gebaseerd op het idee dat pemphigus IgG interfereert met het 
amino-terminale extracellulaire domein van desmogleïnes waardoor transinteractie tussen de 
desmogleïnes en dus adhesie tussen keratinocyten niet mogelijk is. 2) celsignalering: signalerings- 
paden waarbij p38MAPK, RhoA, PKC, plakoglobine en c-myc betrokken zijn lijken een rol te 
spelen in the pathogenese van pemphigus. Er zijn ook aanwijzingen dat signaleringspaden die 
resulteren in apoptose een rol spelen in de pathogenese van pemphigus. 3) verstoring van des-
mosoom opbouw en afbraak: binding van PV IgG aan non-junctioneel Dsg hindert de opbouw 
van desmosomen. Het is ook mogelijk dat PV IgG aan junctioneel Dsg bindt wat resulteert in 
toegenomen afbraak van het desmosoom.
Het doel van dit proefschrift is meer inzicht te verkrijgen in de pathogenese van pemphigus door 
acantholyse in huid van pemphigus patiënten en in een in vitro model van humane huid te bestu-
deren met behulp van licht-, immuunfluorescentie- en elektronenmicroscopie.
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In hoofdstuk 2 beschrijven we de humane cel- en weefselmodellen van pemphigus: het humane 
in vitro huidmodel, celkweken en humane huid getransplanteerd op muizen. Het humane 
in vitro huidmodel vertoont grote gelijkenis met de architectuur van de epidermis in vivo. In 
het model kunnen veranderingen in de morfologie of de lokalisatie van een eiwit eenvoudig 
bestudeerd worden met licht-, immuunfluorescentie- of elektronenmicroscopie. Het in vitro 
model is echter minder geschikt om biochemische vraagstukken met betrekking tot moleculaire 
signaleringspaden te beantwoorden. Monolayers van gekweekte keratinocyten zijn daar wel 
geschikt voor, maar de samenstelling van de desmosomen is niet representatief voor de in vivo 
situatie. In muismodellen met getransplanteerde humane huid kan acantholyse in humane huid 
bestudeerd worden, maar met de voordelen van een diermodel.
In hoofdstuk 3 werd de verdeling van IgG en de desmosomale adhesiemoleculen in huidbiopten 
van 18 patiënten met PV en 10 met PF geanalyseerd met behulp van immuunfluorescentie 
dubbelkleuringen. In PF huid was er een gedeeltelijk granulair patroon te zien bestaande uit IgG 
en Dsg1, maar zonder Dsg3. Omgekeerd was er in de huid van PV patiënten met anti-Dsg3 
antilichamen co-lokalisatie van granulair IgG met Dsg3, maar niet met Dsg1. Plakoglobine 
clusterde mee met IgG en Dsg, maar dit was duidelijker wanneer er Dsg1 betrokken was. 
In tegenstelling tot de gebieden met Dsg3 clustering, was er in de gebieden met forse Dsg1 
clustering intercellulaire verwijding tussen de keratinocyten zichtbaar. Het effect van IgG op 
desmosomale eiwitten werd bestudeerd in een in vitro model. Patiënten IgG, maar niet Fab 
fragmenten induceerde in dit model dezelfde desmogleïne clustering. Deze resultaten leidden tot 
de conclusie dat IgG-geïnduceerde clustering van de desmogleïne autoantigenen de basis vormt 
van de granulaire IgG depositie in patiëntenhuid. In PF en in mucocutane PV huid correleert 
de Dsg1 clustering, maar niet de Dsg3 clustering met non-acantholytische verwijding tussen 
desmosomen. In de patiënt wordt het desmogleïne afgezonderd van de desmosomale compo-
nenten en dit komt overeen met de desmogleïne non-assembly hypothese, wat indiceert dat 
het aangevallen non-junctionele Dsg niet langer beschikbaar is om ingebouwd te worden in de 
desmosomen en dit leidt tot verstoorde opbouw en desmogleïne-gedepleteerde desmosomen.
Om de intercellulaire verwijding tussen de desmosomen in PF huid verder te bestuderen, 
onderzochten we twee Nikolsky negatieve (N-), vijf Nikolsky positieve (N+) en twee lesionale 
PF huidbiopten met licht- en elektronenmicroscopie in hoofdstuk 4. Er werden geen afwijkingen 
gezien in N- PF huid, terwijl alle N+ huidbiopten intercellulaire verwijding tussen de desmo-
somen, een afgenomen aantal desmosomen en hypoplastische desmosomen toonden. 
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Acantholyse was aanwezig in twee van de vijf N+ biopten, maar alleen in de bovenste epider-
male lagen. De lesionale huidbiopten toonden acantholyse in de hogere epidermale lagen. Hy-
poplastische desmosomen waren gedeeltelijk (pseudo-half desmosomen) of volledig afgescheurd 
van de tegenoverliggende cel. Op basis van deze resultaten werd geconcludeerd dat PF IgG 
depletie veroorzaakt van non-junctioneel Dsg1, wat resulteert in intercellulaire verwijding tussen 
de desmosomen. Deze verwijding begint in de lagere lagen en verspreidt zich dan verder naar de 
hogere lagen van de epidermis. Depletie van non-junctioneel Dsg1 belemmert de opbouw van 
desmosomen. Bovendien is het mogelijk dat de autoantilichamen de afbraak van desmosomen 
stimuleren. In de bovenste lagen van de epidermis, waar Dsg3 niet tot expressie komt en niet 
kan compenseren voor het verlies van Dsg1, resulteert de depletie van Dsg1 in het wegsmelten 
van desmosomen en uiteindelijk in acantholyse.
Om de verschillen in de grootte van de desmosomen en het aantal desmosomen te kwantifi-
ceren, werd een morfometrische elektronen microscopie studie uitgevoerd op PF, PV oris en 
mucocutane PV huid in hoofdstuk 5. We bestudeerden de individuele invloed van Dsg1 en Dsg3 
antilichamen op de grootte en het aantal desmosomen in huid van patiënten met PF, PV oris en 
mucocutane PV. IgG, Dsg1 en Dsg3 patronen werden onderzocht met behulp van directe im-
muunfluorescentie microscopie. De grootte en het aantal desmosomen werden onderzocht met 
behulp van elektronenmicroscopie. In N- huid werd minimale clustering van Dsg1 gezien in de 
basale laag, terwijl in N+ PF huid, Dsg1 clustering zich verspreid had over de suprabasale lagen. 
In N+ PF huid waren kleinere en minder desmosomen aanwezig dan in N- PF huid of in controle 
huid. In PV oris huid waren Dsg3 clusters aanwezig en was de expressie van Dsg3 sterk afge-
nomen, maar de desmosomen bleven normaal van grootte en in aantal. In mucocutane PV huid 
met antilichamen gericht tegen zowel Dsg1 als Dsg3 was er geen afname van het aantal en de 
grootte van de desmosomen. Deze resultaten leidden tot de conclusie dat Dsg1, maar niet Dsg3, 
noodzakelijk is voor het behoud van de grootte en aantal desmosomen in humane epidermis en 
dat verlies van Dsg1 een voorwaarde is om cutane acantholyse te ontwikkelen in pemphigus.
Of apoptose een rol speelt in de pathogenese van pemphigus is een steeds terugkerende vraag. 
In hoofdstuk 6 werden daarom 22 biopten van PV en PF patiënten en 8 biopten afkomstig een 
PV en PF in vitro model bestudeerd met behulp van immuunfluorescentie kleuring van gekliefd 
caspase 3, gekliefd caspase 8, PARP, fractin en TUNEL. Bovendien werden biopten van PV en 
PF patiënten met behulp van elektronenmicroscopie onderzocht op morfologische tekenen van 
apoptose. Zowel in patiëntenhuid als in het in vitro model was geen expressie van apoptotische 
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markers aanwezig. In lesionale PF biopten en in de biopten afkomstig van het in vitro model 
werden een aantal TUNEL positieve cellen gezien. Deze resultaten waren echter vergelijkbaar 
met de bevindingen in controle biopten. Geen van de PV en PF huid biopten toonden op 
ultrastructureel niveau morfologische kenmerken van apoptose. De hypothese dat apoptose 
betrokken zou zijn bij acantholyse in pemphigus wordt niet ondersteund door deze resultaten.
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